[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 1290
1. Jakowski JD, Wakely PE Jr: Primary intrathoracic low-grade fibromyxoid sarcoma. Hum Pathol; 2008 Apr;39(4):623-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary intrathoracic low-grade fibromyxoid sarcoma.
  • Low-grade fibromyxoid sarcoma (LGFMS) is a rare neoplasm commonly affecting young adults and typically arising in the somatic soft tissue of the proximal extremities.
  • Diagnosis was aided by a strikingly characteristic light microscopic appearance of a bland spindle cell sarcoma containing numerous so-called giant collagen rosettes and supported by immunohistology, evidence of FUS translocation by fluorescence in situ hybridization, and electron microscopy demonstrating a fibroblastic phenotype.
  • Low-grade fibromyxoid sarcoma is probably an underrecognized intrathoracic neoplasm and should be considered in the differential diagnosis of spindle cell neoplasms of the mediastinum, pleura, heart, and lungs.
  • [MeSH-minor] Adult. Female. Humans. In Situ Hybridization, Fluorescence. Male. Microscopy, Electron. Middle Aged. RNA-Binding Protein FUS / genetics. Translocation, Genetic

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Hum Pathol. 2008 Oct;39(10):1553-4; author reply 1554 [18774378.001]
  • (PMID = 18275982.001).
  • [ISSN] 0046-8177
  • [Journal-full-title] Human pathology
  • [ISO-abbreviation] Hum. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / RNA-Binding Protein FUS
  • [Number-of-references] 30
  •  go-up   go-down


2. Singh RP, Grimer RJ, Bhujel N, Carter SR, Tillman RM, Abudu A: Adult head and neck soft tissue sarcomas: treatment and outcome. Sarcoma; 2008;2008:654987
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adult head and neck soft tissue sarcomas: treatment and outcome.
  • We have retrospectively analysed the experience of a musculoskeletal oncological unit in the management of adult head and neck soft tissue sarcomas from 1990 to 2005.
  • Adult head and neck soft tissue sarcomas have a high mortality rate with a high risk of local recurrence and metastatic disease.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer. 2000 Aug 15;89(4):868-72 [10951351.001]
  • [Cites] Hematol Oncol Clin North Am. 2001 Apr;15(2):377-88, vii [11370499.001]
  • [Cites] Surg Oncol Clin N Am. 2003 Apr;12(2):379-417 [12916461.001]
  • [Cites] World J Surg. 2003 Jul;27(7):875-83 [14509522.001]
  • [Cites] Ann Surg Oncol. 2004 Jun;11(6):619-28 [15172935.001]
  • [Cites] Am J Clin Oncol. 2005 Jun;28(3):259-63 [15923798.001]
  • [Cites] Lancet. 1997 Dec 6;350(9092):1647-54 [9400508.001]
  • [Cites] Laryngoscope. 2006 May;116(5):780-5 [16652087.001]
  • [Cites] Head Neck. 2007 Aug;29(8):731-40 [17274049.001]
  • [Cites] Clin Orthop Relat Res. 1980 Nov-Dec;(153):106-20 [7449206.001]
  • [Cites] Cancer. 1994 Jul 15;74(2):697-702 [8033050.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 1994 Sep;120(9):981-6 [8074826.001]
  • [Cites] Br J Cancer. 1993 Jul;68(1):201-7 [8318414.001]
  • [Cites] Head Neck. 2005 Oct;27(10):916-22 [16136585.001]
  • (PMID = 18382622.001).
  • [ISSN] 1357-714X
  • [Journal-full-title] Sarcoma
  • [ISO-abbreviation] Sarcoma
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Egypt
  • [Other-IDs] NLM/ PMC2276692
  •  go-up   go-down


3. Kunos C, Colussi V, Getty P, Kinsella T: Intraoperative electron radiotherapy for extremity sarcomas does not increase acute or late morbidity. Clin Orthop Relat Res; 2006 May;446:247-52
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Intraoperative electron radiotherapy is used to treat surgical sites that potentially harbor occult tumor immediately after limb-sparing surgical resection of extremity soft tissue sarcomas.
  • In a retrospective study, we evaluated whether intraoperative electron radiotherapy increased 90-day and late (> 90 days) wound complication rates by comparing patients who had adult extremity soft tissue sarcomas treated by limb-sparing surgery and preoperative (n = 14) or postoperative (n = 13) external beam radiotherapy.
  • Our findings suggest intraoperative electron radiotherapy during limb-sparing surgery allows radiation dose escalation without increased 90-day or late-wound complication rates when combined with preoperative or postoperative external beam radiotherapy for patients with extremity soft tissue sarcomas.
  • [MeSH-major] Arm. Intraoperative Care / methods. Leg. Morbidity / trends. Sarcoma / radiotherapy. Sarcoma / surgery
  • [MeSH-minor] Adult. Beta Particles / therapeutic use. Female. Follow-Up Studies. Humans. Male. Middle Aged. Prospective Studies. Radiotherapy, Adjuvant. Time Factors. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16467624.001).
  • [ISSN] 0009-921X
  • [Journal-full-title] Clinical orthopaedics and related research
  • [ISO-abbreviation] Clin. Orthop. Relat. Res.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


Advertisement
4. Antonescu CR, Dal Cin P, Nafa K, Teot LA, Surti U, Fletcher CD, Ladanyi M: EWSR1-CREB1 is the predominant gene fusion in angiomatoid fibrous histiocytoma. Genes Chromosomes Cancer; 2007 Dec;46(12):1051-60
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • EWSR1-CREB1 is a novel translocation recently described in clear cell sarcoma of the GI tract.
  • EWSR1-ATF1, identified in some AFH cases, is the most common genetic abnormality in soft tissue clear cell sarcoma.
  • Thus, identical fusions involving ATF1 and CREB1 are found in two distinct sarcomas, which may be able to transform two different types of mesenchymal precursor cells, unlike most other sarcoma gene fusions.
  • [MeSH-minor] Adolescent. Adult. Aged. Child. Child, Preschool. Cytogenetic Analysis. Female. Gene Expression. Humans. In Situ Hybridization, Fluorescence. Male. Middle Aged. Reverse Transcriptase Polymerase Chain Reaction

  • Genetic Alliance. consumer health - Histiocytoma, angiomatoid fibrous.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • SciCrunch. OMIM: Data: Gene Annotation .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2007 Wiley-Liss, Inc.
  • (PMID = 17724745.001).
  • [ISSN] 1045-2257
  • [Journal-full-title] Genes, chromosomes & cancer
  • [ISO-abbreviation] Genes Chromosomes Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / CREB1 protein, human; 0 / Calmodulin-Binding Proteins; 0 / Cyclic AMP Response Element-Binding Protein; 0 / EWSR1 protein, human; 0 / RNA-Binding Proteins
  •  go-up   go-down


5. Bray F, Engholm G, Hakulinen T, Gislum M, Tryggvadóttir L, Storm HH, Klint A: Trends in survival of patients diagnosed with cancers of the brain and nervous system, thyroid, eye, bone, and soft tissues in the Nordic countries 1964-2003 followed up until the end of 2006. Acta Oncol; 2010 Jun;49(5):673-93
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Trends in survival of patients diagnosed with cancers of the brain and nervous system, thyroid, eye, bone, and soft tissues in the Nordic countries 1964-2003 followed up until the end of 2006.
  • BACKGROUND: Diagnoses of cancer of the brain, thyroid, eye, bone, and soft tissues are categorised by heterogeneity in disease frequency, survival, aetiology and prospects for curative therapy.
  • Relative survival from eye cancer increased with time from approximately 60% in 1964-1968 to 80% 1999-2003, while for bone sarcoma, incidence rates remained stable, mortality rates declined, and 5-year survival increased slightly to around 55-65%.
  • Soft tissue sarcoma incidence and survival have been slowly increasing since the 1960s, with little variation in survival (around 65%) for the most recent period.
  • [MeSH-major] Bone Neoplasms / mortality. Brain Neoplasms / mortality. Eye Neoplasms / mortality. Nervous System Neoplasms / mortality. Soft Tissue Neoplasms / mortality. Thyroid Neoplasms / mortality
  • [MeSH-minor] Adult. Age Distribution. Aged. Aged, 80 and over. Denmark / epidemiology. Female. Finland / epidemiology. Follow-Up Studies. Humans. Iceland / epidemiology. Incidence. Lymphatic Metastasis. Male. Mass Screening. Middle Aged. Mortality / trends. Neoplasm Staging. Norway / epidemiology. Registries. Risk Factors. Survival Analysis. Survival Rate / trends. Sweden / epidemiology

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Eye Cancer.
  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20192877.001).
  • [ISSN] 1651-226X
  • [Journal-full-title] Acta oncologica (Stockholm, Sweden)
  • [ISO-abbreviation] Acta Oncol
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  •  go-up   go-down


6. Siehl JM, Thiel E, Schmittel A, Hütter G, Deckert PM, Szelényi H, Keilholz U: Ifosfamide/liposomal daunorubicin is a well tolerated and active first-line chemotherapy regimen in advanced soft tissue sarcoma: results of a phase II study. Cancer; 2005 Aug 1;104(3):611-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Ifosfamide/liposomal daunorubicin is a well tolerated and active first-line chemotherapy regimen in advanced soft tissue sarcoma: results of a phase II study.
  • BACKGROUND: The anthracycline/ifosfamide combination is the most effective chemotherapy in soft tissue sarcoma.
  • CONCLUSIONS: The combination of Ifosfamide and L-Dauno was found to be a highly active chemotherapy regimen for first-line treatment of soft tissue sarcoma.
  • [MeSH-major] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Sarcoma / drug therapy
  • [MeSH-minor] Adult. Aged. Daunorubicin / administration & dosage. Disease Progression. Drug Administration Schedule. Female. Granulocyte Colony-Stimulating Factor / administration & dosage. Humans. Ifosfamide / administration & dosage. Infusions, Intravenous. Liposomes. Male. Maximum Tolerated Dose. Middle Aged. Survival Rate. Treatment Outcome

  • Genetic Alliance. consumer health - Soft tissue sarcoma.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • Hazardous Substances Data Bank. DAUNORUBICIN .
  • Hazardous Substances Data Bank. IFOSFAMIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2005 American Cancer Society.
  • (PMID = 15968689.001).
  • [ISSN] 0008-543X
  • [Journal-full-title] Cancer
  • [ISO-abbreviation] Cancer
  • [Language] eng
  • [Publication-type] Clinical Trial; Clinical Trial, Phase II; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Liposomes; 143011-72-7 / Granulocyte Colony-Stimulating Factor; UM20QQM95Y / Ifosfamide; ZS7284E0ZP / Daunorubicin
  •  go-up   go-down


7. Tuy BE, Obafemi AA, Beebe KS, Patterson FR: Case report: elevated serum beta human chorionic gonadotropin in a woman with osteosarcoma. Clin Orthop Relat Res; 2008 Apr;466(4):997-1001
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • It also is secreted by gestational trophoblastic tumors, gonadal tumors, and even various nongonadal tumors, including bone and soft tissue sarcomas, as a paraneoplastic syndrome.
  • The literature contains one case report of beta human chorionic gonadotropin production from a primary bone sarcoma occurring in a male patient.
  • Although the clinical diagnosis of a sarcoma was never in doubt, we present this case to emphasize a need to exclude pregnancy in women of childbearing age to avoid delay in biopsy and subsequent management.
  • [MeSH-minor] Adult. Amputation. Biopsy, Needle. Diagnosis, Differential. Fatal Outcome. Female. Humans. Pregnancy. Pregnancy Tests. Up-Regulation

  • Genetic Alliance. consumer health - Osteosarcoma.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Cancer Res Clin Oncol. 2004 Jun;130(6):357-61 [15042358.001]
  • [Cites] Hum Reprod Update. 2006 Nov-Dec;12(6):769-84 [16877746.001]
  • [Cites] Ann Intern Med. 1973 Jan;78(1):39-45 [4734160.001]
  • [Cites] Surg Gynecol Obstet. 1974 May;138(5):747-51 [4362911.001]
  • [Cites] Cancer Res. 1976 Sep;36(9 PT 2):3476-81 [975106.001]
  • [Cites] Cancer. 1976 Oct;38(4):1684-6 [991086.001]
  • [Cites] J Bone Joint Surg Am. 1977 Dec;59(8):1107-11 [591547.001]
  • [Cites] Fertil Steril. 1982 Jun;37(6):773-8 [7115557.001]
  • [Cites] J Bone Joint Surg Am. 1982 Oct;64(8):1121-7 [7130225.001]
  • [Cites] Cancer. 1984 May 15;53(10):2125-8 [6367934.001]
  • [Cites] Cancer. 1985 Dec 1;56(11):2674-82 [2413978.001]
  • [Cites] Arch Pathol Lab Med. 1989 Apr;113(4):416-9 [2468324.001]
  • [Cites] Cancer Res. 1992 Jul 15;52(14):3901-7 [1377600.001]
  • [Cites] J Bone Joint Surg Am. 1996 May;78(5):656-63 [8642021.001]
  • [Cites] Am J Obstet Gynecol. 1972 Jul 15;113(6):751-8 [4673805.001]
  • (PMID = 18288544.001).
  • [ISSN] 0009-921X
  • [Journal-full-title] Clinical orthopaedics and related research
  • [ISO-abbreviation] Clin. Orthop. Relat. Res.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Chorionic Gonadotropin, beta Subunit, Human
  • [Other-IDs] NLM/ PMC2504678
  •  go-up   go-down


8. Zhang PJ, Brooks JS, Goldblum JR, Yoder B, Seethala R, Pawel B, Gorman JH, Gorman RC, Huang JH, Acker M, Narula N: Primary cardiac sarcomas: a clinicopathologic analysis of a series with follow-up information in 17 patients and emphasis on long-term survival. Hum Pathol; 2008 Sep;39(9):1385-95
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Although cardiac sarcomas are rare in comparison to their soft tissue counterparts, they are the second most common type of primary cardiac neoplasm.
  • Tumor grade appeared to be prognostically important in cardiac sarcoma.
  • [MeSH-major] Heart Neoplasms / pathology. Sarcoma / pathology
  • [MeSH-minor] Adolescent. Adult. Aged. Child. Child, Preschool. Combined Modality Therapy. Female. Follow-Up Studies. Humans. Infant. Male. Middle Aged. Survival Analysis

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Ann Thorac Surg. 2000 Jun;69(6):1949-51 [10892961.001]
  • [Cites] Z Kardiol. 2002 Apr;91(4):352-6 [12063709.001]
  • [Cites] J Heart Lung Transplant. 2002 Oct;21(10):1135-9 [12398881.001]
  • [Cites] Rev Esp Cardiol. 2003 Apr;56(4):408-11 [12689577.001]
  • [Cites] Chest. 2003 May;123(5):1766-8 [12740300.001]
  • [Cites] Thorac Cardiovasc Surg. 2004 Apr;52(2):77-81 [15103579.001]
  • [Cites] Ann Surg. 1980 Feb;191(2):127-38 [7362282.001]
  • [Cites] Hum Pathol. 1982 Jul;13(7):640-5 [7084941.001]
  • [Cites] Cancer. 1984 Feb 1;53(3):530-41 [6692258.001]
  • [Cites] Arch Pathol Lab Med. 1985 Oct;109(10):943-5 [3840005.001]
  • [Cites] Chest. 1987 Jul;92(1):177-9 [3595230.001]
  • [Cites] Chest. 1987 Nov;92(5):860-2 [3665601.001]
  • [Cites] Thorac Cardiovasc Surg. 1990 Aug;38 Suppl 2:183-91 [2237900.001]
  • [Cites] Thorac Cardiovasc Surg. 1990 Aug;38 Suppl 2:192-5 [2237901.001]
  • [Cites] Ann Thorac Surg. 1991 Jun;51(6):906-10 [2039319.001]
  • [Cites] Ann Thorac Surg. 1991 Jun;51(6):999-1001 [2039335.001]
  • [Cites] Ann Thorac Surg. 1991 Oct;52(4):886-95 [1929651.001]
  • [Cites] Cancer. 1992 Jan 15;69(2):387-95 [1728367.001]
  • [Cites] Am Heart J. 1992 Jan;123(1):232-4 [1729836.001]
  • [Cites] Aust N Z J Med. 1991 Dec;21(6):881-3 [1818549.001]
  • [Cites] Scand J Thorac Cardiovasc Surg. 1992;26(3):233-6 [1287840.001]
  • [Cites] J Cardiovasc Surg (Torino). 1993 Dec;34(6):529-33 [8300722.001]
  • [Cites] Semin Surg Oncol. 1994 Sep-Oct;10(5):374-82 [7997732.001]
  • [Cites] J Heart Lung Transplant. 1995 Mar-Apr;14(2):382-6 [7779860.001]
  • [Cites] Hum Mol Genet. 1995 Jun;4(6):1097-9 [7655467.001]
  • [Cites] Histopathology. 1997 Apr;30(4):349-52 [9147083.001]
  • [Cites] Jpn Circ J. 1997 Sep;61(9):795-7 [9293411.001]
  • [Cites] Ann Diagn Pathol. 1998 Jun;2(3):167-72 [9845736.001]
  • [Cites] Br J Cancer. 1998 Dec;78(12):1624-8 [9862574.001]
  • [Cites] J Surg Oncol. 1999 Mar;70(3):194-8 [10102352.001]
  • [Cites] Histopathology. 1999 Apr;34(4):295-304 [10231396.001]
  • [Cites] Eur J Cardiothorac Surg. 2006 Jun;29(6):925-32 [16675225.001]
  • [Cites] J Thorac Oncol. 2006 Feb;1(2):188-9 [17409853.001]
  • [Cites] Gen Thorac Cardiovasc Surg. 2007 Jan;55(1):19-22 [17444167.001]
  • [Cites] Oncologist. 2007 Sep;12(9):1134-42 [17914083.001]
  • (PMID = 18602663.001).
  • [ISSN] 1532-8392
  • [Journal-full-title] Human pathology
  • [ISO-abbreviation] Hum. Pathol.
  • [Language] eng
  • [Grant] United States / NHLBI NIH HHS / HL / R01 HL063954
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ NIHMS522251; NLM/ PMC4081532
  •  go-up   go-down


9. Lim HS, Heo SH, Park JG, Kang HK: Metastatic alveolar soft part sarcoma of the breast. J Ultrasound Med; 2006 Jul;25(7):929-32
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metastatic alveolar soft part sarcoma of the breast.
  • [MeSH-major] Breast Neoplasms / secondary. Sarcoma / secondary. Soft Tissue Neoplasms / pathology
  • [MeSH-minor] Adult. Female. Humans

  • Genetic Alliance. consumer health - Alveolar Soft Part Sarcoma.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16798907.001).
  • [ISSN] 0278-4297
  • [Journal-full-title] Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine
  • [ISO-abbreviation] J Ultrasound Med
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 9
  •  go-up   go-down


10. Funovics PT, Dominkus M, Kotz R: [Upper-extremity amputation in tumours of the shoulder and upper arm--experiences of the Vienna Bone Tumour Registry]. Handchir Mikrochir Plast Chir; 2008 Feb;40(1):13-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Malignant lesions of the bones and soft tissues require radical or wide resection to achieve adequate therapy.
  • Therefore, the importance of biopsy in the therapeutical algorithm of bone and soft tissue tumours has to be emphasised again.
  • [MeSH-major] Amputation. Arm / surgery. Artificial Limbs. Bone Neoplasms / surgery. Registries. Shoulder / surgery. Soft Tissue Neoplasms / surgery
  • [MeSH-minor] Adolescent. Adult. Algorithms. Austria. Humans. Humerus / surgery. Limb Salvage. Male. Middle Aged. Osteosarcoma / radiography. Osteosarcoma / surgery. Prosthesis Design. Prosthesis Fitting. Reoperation. Replantation / methods. Sarcoma / surgery

  • MedlinePlus Health Information. consumer health - Artificial Limbs.
  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18322894.001).
  • [ISSN] 0722-1819
  • [Journal-full-title] Handchirurgie, Mikrochirurgie, plastische Chirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft für Handchirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft für Mikrochirurgie der Peripheren Nerven und Gefässe : Organ der Vereinigung der Deutschen Plastischen Chirurgen
  • [ISO-abbreviation] Handchir Mikrochir Plast Chir
  • [Language] ger
  • [Publication-type] Comparative Study; English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


11. Dhingra KK, Mandal S, Roy S, Khurana N: Malignant peripheral nerve sheath tumor of the breast: case report. World J Surg Oncol; 2007;5:142
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Malignant peripheral nerve sheath tumor is a rare soft tissue sarcoma of ectomesenchymal origin.
  • It is the malignant counterpart of benign soft tissue tumors like neurofibromas and schwannomas and may often follow them.
  • Common sites include deeper soft tissues, usually in the proximity of a nerve trunk.
  • [MeSH-minor] Adult. Biomarkers, Tumor / metabolism. Biopsy, Fine-Needle. Diagnosis, Differential. Female. Humans. Vimentin / metabolism

  • Genetic Alliance. consumer health - Malignant peripheral nerve sheath tumor.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Orv Hetil. 1998 Jan 18;139(3):137-9 [9467297.001]
  • [Cites] Cancer. 1984 Sep 15;54(6):1049-57 [6432304.001]
  • [Cites] Cancer. 1986 May 15;57(10):2006-21 [3082508.001]
  • [Cites] Arch Pathol Lab Med. 1988 Feb;112(2):155-60 [2447857.001]
  • [Cites] J Surg Oncol. 1995 Aug;59(4):273-5 [7630177.001]
  • [Cites] J Med Assoc Thai. 2006 Mar;89(3):377-9 [16696423.001]
  • [Cites] Cancer Res. 2002 Mar 1;62(5):1573-7 [11894862.001]
  • [Cites] J Clin Oncol. 1998 Jan;16(1):197-203 [9440743.001]
  • [Cites] Breast J. 2003 Jul-Aug;9(4):332 [12846874.001]
  • [Cites] J Gynecol Obstet Biol Reprod (Paris). 1998 Jun;27(4):441-4 [9690165.001]
  • [Cites] Langenbecks Arch Chir. 1995;380(6):350-3 [8559005.001]
  • (PMID = 18154670.001).
  • [ISSN] 1477-7819
  • [Journal-full-title] World journal of surgical oncology
  • [ISO-abbreviation] World J Surg Oncol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Vimentin
  • [Other-IDs] NLM/ PMC2246134
  •  go-up   go-down


12. Eilber FC, Brennan MF, Riedel E, Alektiar KM, Antonescu CR, Singer S: Prognostic factors for survival in patients with locally recurrent extremity soft tissue sarcomas. Ann Surg Oncol; 2005 Mar;12(3):228-36
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Prognostic factors for survival in patients with locally recurrent extremity soft tissue sarcomas.
  • BACKGROUND: Factors prognostic for survival in patients with locally recurrent extremity soft tissue sarcomas (STS) are poorly defined, thus making it difficult to identify high-risk patients who may benefit from adjuvant therapy.
  • METHODS: A total of 1421 patients underwent surgical treatment for primary extremity STS at a single institution between 1982 and 2002.
  • CONCLUSIONS: Histological grade, local recurrence size, and local recurrence-free interval are independently predictive of survival in patients with locally recurrent extremity STS.
  • [MeSH-major] Extremities. Neoplasm Recurrence, Local. Sarcoma / diagnosis
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Disease-Free Survival. Female. Humans. Lower Extremity / pathology. Lower Extremity / surgery. Male. Middle Aged. Prognosis. Risk Factors. Upper Extremity / pathology. Upper Extremity / surgery

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15827815.001).
  • [ISSN] 1068-9265
  • [Journal-full-title] Annals of surgical oncology
  • [ISO-abbreviation] Ann. Surg. Oncol.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / P01CA47179
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  •  go-up   go-down


13. King JJ, Fayssoux RS, Lackman RD, Ogilvie CM: Early outcomes of soft tissue sarcomas presenting with metastases and treated with chemotherapy. Am J Clin Oncol; 2009 Jun;32(3):308-13
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Early outcomes of soft tissue sarcomas presenting with metastases and treated with chemotherapy.
  • OBJECTIVES: The purpose of this study is to describe outcomes for patients with metastatic soft tissue sarcoma treated with chemotherapy.
  • METHODS: We retrospectively reviewed the records of 383 soft tissue sarcoma patients treated at our institution from 1997 to 2006.
  • Twenty-nine patients (83%) presented with pulmonary metastasis, 6 with bone metastases (17%), 4 with regional node metastases (11%), and 4 with soft tissue metastases (11%).
  • CONCLUSIONS: Soft tissue sarcoma patients presenting with metastatic disease have a low survival rate, but complete eradication of tumor correlated with longer survival.
  • [MeSH-major] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Sarcoma / drug therapy. Soft Tissue Neoplasms / drug therapy
  • [MeSH-minor] Adolescent. Adult. Aged. Bone Neoplasms / secondary. Female. Follow-Up Studies. Humans. Lung Neoplasms / secondary. Lymphatic Metastasis. Male. Middle Aged. Neoplasm Staging. Prognosis. Retrospective Studies. Survival Rate. Treatment Outcome. Young Adult

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19433963.001).
  • [ISSN] 1537-453X
  • [Journal-full-title] American journal of clinical oncology
  • [ISO-abbreviation] Am. J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


14. MacDougall RH, Kerr GR, Duncan W: Incidence of sarcoma in patients treated with fast neutrons. Int J Radiat Oncol Biol Phys; 2006 Nov 1;66(3):842-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Incidence of sarcoma in patients treated with fast neutrons.
  • PURPOSE: The aim of this study is to report the incidence of soft tissue sarcoma in a large group of patients treated with fast neutrons.
  • The main outcome measure was the incidence of new soft-tissue sarcomas during long-term follow-up.
  • RESULTS: Three cases of sarcoma, developing within the treatment volume, were observed in a small group of patients treated some years earlier using fast neutrons.
  • [MeSH-major] Fast Neutrons / adverse effects. Neoplasms, Radiation-Induced / epidemiology. Neoplasms, Second Primary / epidemiology. Sarcoma / epidemiology
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Carcinoma, Squamous Cell / radiotherapy. Female. Fibrosarcoma / radiotherapy. Follow-Up Studies. Head and Neck Neoplasms / radiotherapy. Humans. Incidence. Male. Middle Aged. Randomized Controlled Trials as Topic. Scotland / epidemiology. Thigh

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17011455.001).
  • [ISSN] 0360-3016
  • [Journal-full-title] International journal of radiation oncology, biology, physics
  • [ISO-abbreviation] Int. J. Radiat. Oncol. Biol. Phys.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


15. Burris HA 3rd, Infante JR, Jewell RC, Spigel DR, Greco FA, Thompson DS, Jones SF: A phase I study of weekly topotecan in combination with pemetrexed in patients with advanced malignancies. Oncologist; 2010;15(9):954-60
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • One non-small cell lung cancer (NSCLC) patient (12 months) and one soft tissue sarcoma patient (6 months) achieved a partial response.
  • [MeSH-minor] Adult. Aged. Female. Glutamates / administration & dosage. Glutamates / adverse effects. Guanine / administration & dosage. Guanine / adverse effects. Guanine / analogs & derivatives. Humans. Male. Middle Aged. Pemetrexed. Topotecan / administration & dosage. Topotecan / adverse effects

  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • Hazardous Substances Data Bank. Topotecan .
  • Hazardous Substances Data Bank. PEMETREXED .
  • Hazardous Substances Data Bank. GUANINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Oncol. 1994 Feb;12(2):347-52 [8113842.001]
  • [Cites] J Clin Oncol. 2004 May 1;22(9):1589-97 [15117980.001]
  • [Cites] Ann Oncol. 1997 Oct;8(10):1003-8 [9402174.001]
  • [Cites] Br J Cancer. 1997;76(12):1636-9 [9413954.001]
  • [Cites] Am J Clin Oncol. 1998 Oct;21(5):438-41 [9781595.001]
  • [Cites] J Clin Oncol. 1999 Apr;17(4):1194 [10561178.001]
  • [Cites] Lung Cancer. 2000 May;28(2):157-62 [10717333.001]
  • [Cites] Clin Cancer Res. 2000 Mar;6(3):868-73 [10741709.001]
  • [Cites] Cancer Chemother Pharmacol. 2001;47(2):141-8 [11269740.001]
  • [Cites] Cancer Invest. 2001;19(5):467-74 [11458814.001]
  • [Cites] Oncology. 2001;61 Suppl 1:30-4 [11598412.001]
  • [Cites] Oncology. 2001;61 Suppl 1:35-41 [11598413.001]
  • [Cites] Oncology. 2001;61 Suppl 1:47-54 [11598415.001]
  • [Cites] Ann Oncol. 2002 May;13(5):737-41 [12075742.001]
  • [Cites] Cancer. 2002 Sep 15;95(6):1274-8 [12216095.001]
  • [Cites] Oncologist. 2002;7(6):509-15 [12490738.001]
  • [Cites] Lung Cancer. 2003 Feb;39(2):215-9 [12581576.001]
  • [Cites] Ann Oncol. 2003 Mar;14(3):455-60 [12598353.001]
  • [Cites] Cancer Invest. 2003;21(4):517-25 [14533441.001]
  • [Cites] J Clin Oncol. 1996 Feb;14(2):503-13 [8636764.001]
  • (PMID = 20798192.001).
  • [ISSN] 1549-490X
  • [Journal-full-title] The oncologist
  • [ISO-abbreviation] Oncologist
  • [Language] eng
  • [Publication-type] Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Glutamates; 04Q9AIZ7NO / Pemetrexed; 5Z93L87A1R / Guanine; 7M7YKX2N15 / Topotecan
  • [Other-IDs] NLM/ PMC3228036
  •  go-up   go-down


16. Kilvaer TK, Valkov A, Sorbye S, Smeland E, Bremnes RM, Busund LT, Donnem T: Profiling of VEGFs and VEGFRs as prognostic factors in soft tissue sarcoma: VEGFR-3 is an independent predictor of poor prognosis. PLoS One; 2010;5(12):e15368
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Profiling of VEGFs and VEGFRs as prognostic factors in soft tissue sarcoma: VEGFR-3 is an independent predictor of poor prognosis.
  • BACKGROUND: In non-gastrointestinal stromal tumor soft tissue sarcoma (non-GIST STS) optimal treatment is surgery with wide resection margins.
  • This study investigates the prognostic impact of VEGFs and VEGFRs in non-GIST STS with wide and non-wide resection margins.
  • METHODS: Tumor samples from 249 patients with non-GIST STS were obtained and tissue microarrays were constructed for each specimen.
  • [MeSH-major] Gene Expression Profiling. Receptors, Vascular Endothelial Growth Factor / metabolism. Sarcoma / metabolism. Soft Tissue Neoplasms / metabolism. Vascular Endothelial Growth Factor A / metabolism
  • [MeSH-minor] Adult. Aged. Disease-Free Survival. Female. Humans. Lymphangiogenesis. Male. Middle Aged. Neovascularization, Pathologic. Prognosis. Vascular Endothelial Growth Factor Receptor-3 / metabolism

  • Genetic Alliance. consumer health - Soft tissue sarcoma.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Br J Surg. 2004 Feb;91(2):242-7 [14760675.001]
  • [Cites] Br J Cancer. 2001 Jun 15;84(12):1610-5 [11401313.001]
  • [Cites] Nat Rev Cancer. 2004 Oct;4(10):806-13 [15510161.001]
  • [Cites] Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3566-70 [7724599.001]
  • [Cites] N Engl J Med. 1995 Dec 28;333(26):1757-63 [7491141.001]
  • [Cites] J Clin Oncol. 1997 Jan;15(1):350-62 [8996162.001]
  • [Cites] J Cancer Res Clin Oncol. 1999 Oct;125(10):577-81 [10473871.001]
  • [Cites] Cardiovasc Res. 2005 Feb 15;65(3):550-63 [15664381.001]
  • [Cites] ANZ J Surg. 2006 Mar;76(3):104-9 [16626341.001]
  • [Cites] Cancer Metastasis Rev. 2006 Jun;25(2):221-32 [16770534.001]
  • [Cites] Histopathology. 2006 Jul;49(1):87-8 [16842251.001]
  • [Cites] Cancer. 2007 Mar 1;109(5):813-9 [17265525.001]
  • [Cites] Nat Rev Mol Cell Biol. 2007 Jun;8(6):464-78 [17522591.001]
  • [Cites] J Exp Med. 2007 Jun 11;204(6):1431-40 [17535974.001]
  • [Cites] Ann N Y Acad Sci. 2008;1131:225-34 [18519975.001]
  • [Cites] Nature. 2008 Jul 31;454(7204):656-60 [18594512.001]
  • [Cites] Ann Surg Oncol. 2001 Apr;8(3):260-7 [11314944.001]
  • [Cites] Oncologist. 2008 Nov;13(11):1193-200 [18987047.001]
  • [Cites] CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49 [19474385.001]
  • [Cites] Clin Cancer Res. 2009 Aug 15;15(16):5191-8 [19671876.001]
  • [Cites] Clin Oncol (R Coll Radiol). 2009 Nov;21(9):695-705 [19734027.001]
  • [Cites] Eur J Cancer. 2010 Jan;46(1):6-8 [19926474.001]
  • [Cites] Cancer. 2010 Mar 1;116(5):1177-83 [20052715.001]
  • [Cites] Ann Surg Oncol. 2007 Oct;14(10):2876-86 [17647063.001]
  • [Cites] Clin Cancer Res. 2007 Nov 15;13(22 Pt 1):6649-57 [18006765.001]
  • [Cites] J Surg Oncol. 2008 Jan 1;97(1):74-81 [18041747.001]
  • [Cites] Ann Oncol. 2004 Aug;15(8):1261-6 [15277268.001]
  • (PMID = 21179485.001).
  • [ISSN] 1932-6203
  • [Journal-full-title] PloS one
  • [ISO-abbreviation] PLoS ONE
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Vascular Endothelial Growth Factor A; EC 2.7.10.1 / Receptors, Vascular Endothelial Growth Factor; EC 2.7.10.1 / Vascular Endothelial Growth Factor Receptor-3
  • [Other-IDs] NLM/ PMC3001883
  •  go-up   go-down


17. Ueda T, Naka N, Araki N, Ishii T, Tsuchiya H, Yoshikawa H, Mochizuki K, Tsuboyama T, Toguchida J, Ozaki T, Murata H, Kudawara I, Tanaka K, Iwamoto Y, Yazawa Y, Kushida K, Otsuka T, Sato K: Validation of radiographic response evaluation criteria of preoperative chemotherapy for bone and soft tissue sarcomas: Japanese Orthopaedic Association Committee on Musculoskeletal Tumors Cooperative Study. J Orthop Sci; 2008 Jul;13(4):304-12
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Validation of radiographic response evaluation criteria of preoperative chemotherapy for bone and soft tissue sarcomas: Japanese Orthopaedic Association Committee on Musculoskeletal Tumors Cooperative Study.
  • BACKGROUND: The radiographic evaluation of the response to preoperative chemotherapy for bone and soft tissue sarcomas is based mostly on the change in primary tumor size before and after chemotherapy, as is done for many solid cancers.
  • METHODS: We conducted a retrospective validation study of the Japanese Orthopaedic Association (JOA) radiographic response evaluation criteria of preoperative chemotherapy for bone and soft tissue sarcomas as a JOA Committee on Musculoskeletal Tumors cooperative study.
  • A total of 125 consecutive patients with high-grade bone (n = 77) and soft tissue (n = 48) sarcomas treated with neoadjuvant chemotherapy and definitive surgery in 25 tertiary referral hospitals were selected for the study.
  • We investigated the correlation between the tumor size-based radiographic response evaluation criteria of preoperative chemotherapy for bone and soft tissue sarcomas provided by the JOA Committee on Musculoskeletal Tumors (hereafter called the JOA criteria) and the patients' overall survival using the Kaplan-Meier method and the log-rank test.
  • RESULTS: The JOA criteria correlated relatively well with survival for malignant bone tumors (mostly comprising osteosarcoma and Ewing's sarcoma) but not for soft tissue sarcomas, suggesting that the tumor size-based radiographic evaluation criteria for the response to preoperative chemotherapy in patients with soft tissue sarcomas is invalid.
  • CONCLUSIONS: The JOA criteria, based on the change in primary tumor size, is valid for malignant bone tumors but invalid for soft tissue sarcomas.
  • Other new evaluation modalities of the response to preoperative chemotherapy using innovative functional imaging techniques are needed for soft tissue sarcomas.
  • [MeSH-major] Antineoplastic Agents, Alkylating / therapeutic use. Bone Neoplasms / drug therapy. Bone Neoplasms / radiography. Sarcoma / drug therapy. Sarcoma / radiography
  • [MeSH-minor] Adolescent. Adult. Aged. Chemotherapy, Adjuvant. Child. Child, Preschool. Cohort Studies. Female. Humans. Male. Middle Aged. Practice Guidelines as Topic. Predictive Value of Tests. Retrospective Studies. Survival Analysis. Young Adult

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer. 2007 Feb 15;109(4):767-75 [17238190.001]
  • [Cites] J Bone Joint Surg Am. 1993 Apr;75(4):526-31 [8386728.001]
  • [Cites] J Natl Cancer Inst. 2000 Feb 2;92(3):205-16 [10655437.001]
  • [Cites] J Clin Oncol. 2001 Mar 15;19(6):1818-29 [11251014.001]
  • [Cites] J Clin Oncol. 2001 Jul 1;19(13):3203-9 [11432887.001]
  • [Cites] J Clin Oncol. 2002 Feb 1;20(3):776-90 [11821461.001]
  • [Cites] J Orthop Sci. 2002;7(3):304-12 [12077654.001]
  • [Cites] Cancer. 2002 Sep 1;95(5):1120-6 [12209699.001]
  • [Cites] N Engl J Med. 2003 Feb 20;348(8):694-701 [12594313.001]
  • [Cites] J Clin Oncol. 1993 Sep;11(9):1763-9 [8355043.001]
  • [Cites] Cancer. 1997 Jan 15;79(2):411-5 [9010116.001]
  • [Cites] J Clin Oncol. 1998 Jul;16(7):2452-8 [9667263.001]
  • [Cites] J Bone Joint Surg Am. 1998 Jul;80(7):1020-33 [9698007.001]
  • [Cites] J Clin Oncol. 2004 Nov 15;22(22):4442-5 [15483011.001]
  • [Cites] Arch Dis Child. 2005 Jun;90(6):608-11 [15908626.001]
  • [Cites] Curr Oncol Rep. 2005 Jul;7(4):307-11 [15946591.001]
  • [Cites] Clin Cancer Res. 2005 Jul 15;11(14):5223-32 [16033840.001]
  • [Cites] J Clin Oncol. 2005 Dec 1;23(34):8828-34 [16314643.001]
  • [Cites] Nat Rev Cancer. 2006 May;6(5):409-14 [16633367.001]
  • [Cites] Eur J Cancer. 2006 May;42(8):1031-9 [16616487.001]
  • [Cites] J Clin Oncol. 2006 Jul 10;24(20):3245-51 [16829648.001]
  • [Cites] Clin Orthop Relat Res. 2007 Feb;455:219-24 [17016226.001]
  • [Cites] J Orthop Sci. 2003;8(3):435-41 [12768492.001]
  • [Cites] J Comput Assist Tomogr. 2003 May-Jun;27(3):380-4 [12794603.001]
  • [Cites] Ann Oncol. 2004 Feb;15(2):257-60 [14760119.001]
  • [Cites] J Clin Oncol. 2007 May 1;25(13):1760-4 [17470866.001]
  • (PMID = 18696187.001).
  • [ISSN] 0949-2658
  • [Journal-full-title] Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association
  • [ISO-abbreviation] J Orthop Sci
  • [Language] eng
  • [Publication-type] Journal Article; Validation Studies
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Alkylating
  • [Other-IDs] NLM/ PMC2779413
  •  go-up   go-down


18. Lee S, Lee MR, Lee SJ, Ahn HK, Yi J, Yi SY, Seo SW, Sung KS, Park JO, Lee J: Extraosseous osteosarcoma: single institutional experience in Korea. Asia Pac J Clin Oncol; 2010 Jun;6(2):126-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • AIM: Extraosseous osteosarcoma (EOO) is a rare soft tissue form of osteosarcoma without involvement of the skeletal system.
  • CONCLUSION: EOO should be treated as a soft tissue sarcoma with aggressive behavior and multimodality treatment should be actively sought to improve treatment outcome.
  • [MeSH-major] Osteosarcoma / therapy. Soft Tissue Neoplasms / therapy
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Bone Neoplasms / pathology. Bone Neoplasms / therapy. Chemotherapy, Adjuvant. Disease-Free Survival. Female. Humans. Korea. Male. Middle Aged. Prognosis. Retrospective Studies. Survival Analysis. Treatment Outcome. Young Adult

  • Genetic Alliance. consumer health - Osteosarcoma.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20565425.001).
  • [ISSN] 1743-7563
  • [Journal-full-title] Asia-Pacific journal of clinical oncology
  • [ISO-abbreviation] Asia Pac J Clin Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Australia
  •  go-up   go-down


19. Shi X, Matsumoto S, Manbe J, Tanizawa T, Hoshi M, Sigemitsu T, Izawa N, Takeuchi K, Kawaguchi N: Long-term survival of soft tissue sarcoma patients with extrapulmonary metastasis. J Orthop Sci; 2006 Jan;11(1):92-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Long-term survival of soft tissue sarcoma patients with extrapulmonary metastasis.
  • [MeSH-major] Sarcoma / pathology. Soft Tissue Neoplasms / pathology
  • [MeSH-minor] Adult. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Axilla. Buttocks. Combined Modality Therapy. Female. Humans. Leg. Magnetic Resonance Imaging. Male. Middle Aged. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Soft tissue sarcoma.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16437357.001).
  • [ISSN] 0949-2658
  • [Journal-full-title] Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association
  • [ISO-abbreviation] J Orthop Sci
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


20. Berger F, Winkler EC, Ruderer C, Reiser MF: [Imaging of soft tissue sarcomas: standard approaches and new strategies]. Chirurg; 2009 Mar;80(3):175-85
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Imaging of soft tissue sarcomas: standard approaches and new strategies].
  • Soft tissue sarcomas are rare malignant neoplasms accounting for only 1% of malignant tumors in adults.
  • [MeSH-major] Diagnostic Imaging. Sarcoma / diagnosis. Soft Tissue Neoplasms / diagnosis
  • [MeSH-minor] Adult. Chemotherapy, Adjuvant. Combined Modality Therapy. Disease Progression. Disease-Free Survival. Extremities / pathology. Extremities / surgery. Follow-Up Studies. Humans. Neoplasm Invasiveness / pathology. Neoplasm Staging. Neoplasms, Radiation-Induced / diagnosis. Neoplasms, Radiation-Induced / drug therapy. Neoplasms, Radiation-Induced / pathology. Neoplasms, Radiation-Induced / surgery. Neovascularization, Pathologic / diagnosis. Neovascularization, Pathologic / drug therapy. Neovascularization, Pathologic / pathology. Neovascularization, Pathologic / surgery. Prognosis. Radiotherapy, Adjuvant. Sensitivity and Specificity

  • MedlinePlus Health Information. consumer health - Diagnostic Imaging.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Expert Rev Anticancer Ther. 2006 Aug;6(8):1251-60 [16925491.001]
  • [Cites] Eur Radiol. 2005 Dec;15(12):2448-56 [16132930.001]
  • [Cites] J Natl Cancer Inst. 2000 Feb 2;92 (3):205-16 [10655437.001]
  • [Cites] Cancer Imaging. 2008 Oct 04;8 Spec No A:S61-8 [18852082.001]
  • [Cites] Nat Rev Drug Discov. 2007 Sep;6(9):734-45 [17690708.001]
  • [Cites] AJR Am J Roentgenol. 1988 Mar;150(3):615-20 [3257620.001]
  • [Cites] Curr Opin Oncol. 2006 Jul;18(4):369-73 [16721133.001]
  • [Cites] N Engl J Med. 2001 Apr 5;344(14):1052-6 [11287975.001]
  • [Cites] Arch Surg. 1999 Feb;134(2):190-4 [10025462.001]
  • [Cites] Clin Orthop Relat Res. 2008 Sep;466(9):2071-80 [18516656.001]
  • [Cites] J Clin Oncol. 1996 May;14(5):1679-89 [8622088.001]
  • [Cites] Radiology. 1995 Dec;197(3):831-9 [7480764.001]
  • [Cites] Ther Clin Risk Manag. 2007 Jun;3(2):341-8 [18360643.001]
  • [Cites] Ann Oncol. 2005 Jul;16(7):1054-60 [15917312.001]
  • [Cites] J Bone Joint Surg Am. 1996 May;78(5):650-5 [8642020.001]
  • [Cites] Ann Surg. 1998 Sep;228(3):355-65 [9742918.001]
  • [Cites] Cancer. 1994 Mar 15;73(6):1652-9 [8156492.001]
  • [Cites] Eur J Cancer. 2003 Jul;39(11):1568-76 [12855264.001]
  • [Cites] J Clin Oncol. 1997 Aug;15(8):2832-9 [9256126.001]
  • [Cites] Clin Cancer Res. 2005 Sep 1;11(17 ):6171-6 [16144917.001]
  • [Cites] Cancer Imaging. 2008 Mar 25;8:81-6 [18390391.001]
  • [Cites] Ann Surg. 1987 May;205(5):473-81 [3579397.001]
  • [Cites] World J Gastroenterol. 2006 Feb 7;12(5):703-8 [16521182.001]
  • [Cites] Cancer. 2005 Aug 15;104(4):669-75 [16003776.001]
  • [Cites] Abdom Imaging. 2006 Mar-Apr;31(2):188-93 [16447089.001]
  • [Cites] CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96 [18287387.001]
  • [Cites] Eur J Cancer. 2003 Sep;39(14 ):2012-20 [12957455.001]
  • [Cites] Hematol Oncol Clin North Am. 2005 Jun;19(3):471-87, vi [15939192.001]
  • [Cites] Radiol Clin North Am. 1993 Mar;31(2):359-72 [8446754.001]
  • [Cites] J Clin Oncol. 2007 May 1;25(13):1753-9 [17470865.001]
  • [Cites] AJR Am J Roentgenol. 2004 Dec;183(6):1619-28 [15547201.001]
  • [Cites] Ann Surg. 1982 Sep;196(3):305-15 [7114936.001]
  • [Cites] Int J Hyperthermia. 2002 Nov-Dec;18(6):486-9 [12537749.001]
  • (PMID = 19224185.001).
  • [ISSN] 1433-0385
  • [Journal-full-title] Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen
  • [ISO-abbreviation] Chirurg
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Germany
  • [Number-of-references] 39
  •  go-up   go-down


21. Ng VY, Thomas K, Crist M, Wakely PE Jr, Mayerson J: Fine needle aspiration for clinical triage of extremity soft tissue masses. Clin Orthop Relat Res; 2010 Apr;468(4):1120-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Fine needle aspiration for clinical triage of extremity soft tissue masses.
  • BACKGROUND: Fine needle aspiration cytology (FNAC) is a rapid and low-morbid alternative to open biopsy or needle core biopsy for soft tissue masses.
  • METHODS: We retrospectively examined the diagnostic accuracy and clinical effectiveness of office-based FNAC performed by a trained pathologist on 213 females and 219 males (mean age, 51.8 years) who presented with a palpable soft tissue mass to one musculoskeletal oncology clinic between 2002 and 2008.
  • Final tissue confirmation by open biopsy or resection was available for 52.2% of benign FNAC and 78.3% of malignant FNAC.
  • [MeSH-major] Biopsy, Fine-Needle. Extremities / pathology. Sarcoma / pathology. Soft Tissue Neoplasms / pathology. Triage / methods
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Female. Humans. Male. Middle Aged. Predictive Value of Tests. Reproducibility of Results. Retrospective Studies. Young Adult

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Acta Cytol. 2000 May-Jun;44(3):337-43 [10833988.001]
  • [Cites] CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96 [18287387.001]
  • [Cites] Am J Clin Pathol. 2001 Jan;115(1):59-68 [11190808.001]
  • [Cites] Diagn Cytopathol. 2001 May;24(5):307-16 [11335959.001]
  • [Cites] Acta Orthop Scand. 2001 Apr;72(2):150-9 [11372946.001]
  • [Cites] Cancer Control. 2001 May-Jun;8(3):232-8 [11378649.001]
  • [Cites] Acta Orthop Scand Suppl. 2001 Feb;72(300):1-31 [11381580.001]
  • [Cites] Diagn Cytopathol. 2002 Apr;26(4):232-42 [11933269.001]
  • [Cites] Cancer. 2002 Apr 25;96(2):83-91 [11954025.001]
  • [Cites] Diagn Cytopathol. 2002 Jul;27(1):1-4 [12112806.001]
  • [Cites] Diagn Cytopathol. 2002 Dec;27(6):354-61 [12451566.001]
  • [Cites] Cytopathology. 2003 Aug;14(4):173-82 [12873307.001]
  • [Cites] Adv Anat Pathol. 2004 Jan;11(1):24-37 [14676638.001]
  • [Cites] Cytopathology. 2004 Feb;15(1):32-7 [14748789.001]
  • [Cites] Arch Pathol Lab Med. 2004 Jul;128(7):759-64 [15214827.001]
  • [Cites] Acta Orthop Scand. 1985 Oct;56(5):407-12 [4072661.001]
  • [Cites] Arch Pathol Lab Med. 1986 May;110(5):420-4 [3754426.001]
  • [Cites] Acta Cytol. 1986 Nov-Dec;30(6):671-8 [3466503.001]
  • [Cites] J Surg Oncol. 1988 Mar;37(3):168-70 [3352270.001]
  • [Cites] Hum Pathol. 1990 Jun;21(6):669-77 [2190911.001]
  • [Cites] Surgery. 1992 Sep;112(3):536-43 [1519170.001]
  • [Cites] Acta Cytol. 1994 May-Jun;38(3):381-4 [8191828.001]
  • [Cites] Cytopathology. 1995 Aug;6(4):236-47 [8520003.001]
  • [Cites] J Bone Joint Surg Am. 1996 May;78(5):639-43 [8642018.001]
  • [Cites] J Bone Joint Surg Am. 1996 May;78(5):644-9 [8642019.001]
  • [Cites] J Bone Joint Surg Am. 1996 May;78(5):656-63 [8642021.001]
  • [Cites] Am J Surg. 1997 Dec;174(6):694-6; discussion 697-8 [9409599.001]
  • [Cites] Cytopathology. 1998 Oct;9(5):320-8 [9800130.001]
  • [Cites] Virchows Arch. 1999 Mar;434(3):187-91 [10190296.001]
  • [Cites] Am J Clin Pathol. 1999 May;111(5):632-40 [10230353.001]
  • [Cites] Am J Clin Pathol. 2005 Mar;123(3):388-93 [15716235.001]
  • [Cites] Ann Diagn Pathol. 2005 Aug;9(4):197-201 [16084452.001]
  • [Cites] Cancer. 2005 Aug 25;105(4):229-39 [15918176.001]
  • [Cites] N Engl J Med. 2005 Aug 18;353(7):701-11 [16107623.001]
  • [Cites] Mod Pathol. 2006 Jun;19(6):815-9 [16557276.001]
  • [Cites] Clin Orthop Relat Res. 2006 Sep;450:95-100 [16906075.001]
  • [Cites] Diagn Cytopathol. 2007 Dec;35(12):768-73 [18008345.001]
  • [Cites] Cancer. 2007 Dec 25;111(6):491-8 [17941014.001]
  • [Cites] Cancer. 2000 Oct 25;90(5):292-8 [11038426.001]
  • (PMID = 19763717.001).
  • [ISSN] 1528-1132
  • [Journal-full-title] Clinical orthopaedics and related research
  • [ISO-abbreviation] Clin. Orthop. Relat. Res.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC2835602
  •  go-up   go-down


22. Patel S, Keohan ML, Saif MW, Rushing D, Baez L, Feit K, DeJager R, Anderson S: Phase II study of intravenous TZT-1027 in patients with advanced or metastatic soft-tissue sarcomas with prior exposure to anthracycline-based chemotherapy. Cancer; 2006 Dec 15;107(12):2881-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Phase II study of intravenous TZT-1027 in patients with advanced or metastatic soft-tissue sarcomas with prior exposure to anthracycline-based chemotherapy.
  • In addition, Phase I clinical investigations suggested activity in STS (soft-tissue sarcoma).
  • METHODS: Eligible patients were those who had histologic evidence of locally advanced or metastatic STS and who had received 1 prior treatment regimen with an anthracycline-based chemotherapy for metastatic disease.
  • [MeSH-major] Antineoplastic Agents / therapeutic use. Oligopeptides / therapeutic use. Sarcoma / drug therapy
  • [MeSH-minor] Adult. Aged. Anthracyclines / therapeutic use. Antineoplastic Combined Chemotherapy Protocols. Constipation / chemically induced. Fatigue / chemically induced. Female. Humans. Injections, Intravenous. Male. Middle Aged. Neutropenia / chemically induced

  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2006 American Cancer Society.
  • (PMID = 17109446.001).
  • [ISSN] 0008-543X
  • [Journal-full-title] Cancer
  • [ISO-abbreviation] Cancer
  • [Language] eng
  • [Publication-type] Clinical Trial, Phase II; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Anthracyclines; 0 / Antineoplastic Agents; 0 / Oligopeptides; DQC51A0WQH / soblidotin
  •  go-up   go-down


23. Jin Y, Shima Y, Furu M, Aoyama T, Nakamata T, Nakayama T, Nakamura T, Toguchida J: Absence of oncogenic mutations of RAS family genes in soft tissue sarcomas of 100 Japanese patients. Anticancer Res; 2010 Jan;30(1):245-51
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Absence of oncogenic mutations of RAS family genes in soft tissue sarcomas of 100 Japanese patients.
  • MATERIALS AND METHODS: Mutation analyses of three RAS genes (KRAS, HRAS and NRAS) were performed using polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) analyses and PCR direct sequencing in one hundred cases of soft tissue sarcoma (STS) as well as six STS cell lines from Japanese patients.
  • CONCLUSION: Activating mutations of the RAS gene family are uncommon events in soft tissue sarcomas in Japanese patients.
  • [MeSH-major] Genes, ras. Sarcoma / genetics
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Cell Line, Tumor. Child. DNA Mutational Analysis. Female. Humans. Japan. Male. Middle Aged. Polymerase Chain Reaction. Polymorphism, Single-Stranded Conformational. Young Adult

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20150643.001).
  • [ISSN] 1791-7530
  • [Journal-full-title] Anticancer research
  • [ISO-abbreviation] Anticancer Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Greece
  •  go-up   go-down


24. Baker LH, Rowinsky EK, Mendelson D, Humerickhouse RA, Knight RA, Qian J, Carr RA, Gordon GB, Demetri GD: Randomized, phase II study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 in patients with advanced soft tissue sarcoma. J Clin Oncol; 2008 Dec 1;26(34):5583-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Randomized, phase II study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 in patients with advanced soft tissue sarcoma.
  • Phase I study results for ABT-510, which inhibits angiogenesis via a novel thrombospondin-mimetic mechanism, suggested activity in soft tissue sarcoma (STS) patients.
  • This phase II study further evaluated the safety and efficacy of ABT-510 in advanced STS patients.
  • PATIENTS AND METHODS: Patients with metastatic or unresectable STS were randomly assigned to treatment with one of two ABT-510 dose schedules (20 mg once a day [20 mg], n = 42; or 100 mg twice a day [200 mg], n = 46), which were self-administered subcutaneously in 28-day treatment periods.
  • However, with low ORR and lack of dose response, the study failed to yield compelling evidence of strong single-agent activity in STS.
  • [MeSH-major] Angiogenesis Inhibitors / pharmacology. Oligopeptides / pharmacokinetics. Oligopeptides / pharmacology. Sarcoma / drug therapy. Thrombospondin 1 / metabolism
  • [MeSH-minor] Adult. Disease-Free Survival. Female. Humans. Male. Maximum Tolerated Dose. Middle Aged. Neovascularization, Pathologic. Odds Ratio. Retrospective Studies. Treatment Outcome

  • Genetic Alliance. consumer health - Soft tissue sarcoma.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18981463.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Angiogenesis Inhibitors; 0 / NAc-Sar-Gly-Val-(d-allo-Ile)-Thr-Nva-Ile-Arg-ProNEt; 0 / Oligopeptides; 0 / Thrombospondin 1
  •  go-up   go-down


25. Yang P, Yang LH, Gu LJ, Wang JY: [Feasibility of thoracoscopic pulmonary metastasectomy]. Ai Zheng; 2005 Oct;24(10):1249-51
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Postoperative locoregional relapse occurred in 5 patients, in which 4 patients had multiple metastases, the rest 1 patient with soft tissue sarcoma underwent a second thoracoscopic resection of recurrent pulmonary lesion.
  • [MeSH-minor] Adult. Aged. Breast Neoplasms / pathology. Colorectal Neoplasms / pathology. Feasibility Studies. Female. Follow-Up Studies. Humans. Male. Middle Aged. Neoplasm Recurrence, Local / surgery. Reoperation. Retrospective Studies. Survival Rate

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16219142.001).
  • [Journal-full-title] Ai zheng = Aizheng = Chinese journal of cancer
  • [ISO-abbreviation] Ai Zheng
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  •  go-up   go-down


26. Domanski HA, Mertens F, Panagopoulos I, Akerman M: Low-grade fibromyxoid sarcoma is difficult to diagnose by fine needle aspiration cytology: a cytomorphological study of eight cases. Cytopathology; 2009 Oct;20(5):304-14
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Low-grade fibromyxoid sarcoma is difficult to diagnose by fine needle aspiration cytology: a cytomorphological study of eight cases.
  • BACKGROUND: Low-grade fibromyxoid sarcoma (LGFMS) is an uncommon neoplasm with bland morphology and an indolent clinical course, although metastases may develop in approximately 5-10% of the cases.
  • Tumours arose in the deep soft tissues of the thigh (n = 5), shoulder girdle (n = 1) or upper arm (n = 1) and one in the subcutaneous tissue of the abdominal wall.
  • Cytological features included clusters of bland spindle and round/polygonal cells embedded in a collagenous and myxoid matrix along with dissociated, uniform or slightly/moderately pleomorphic spindle cells, bare nuclei and fragments of collagen and myxoid tissue in varying proportions.
  • Unequivocal sarcoma was diagnosed in two aspirates, but mitoses were absent in all cases.
  • CONCLUSIONS: There were no cytomorphological findings in FNAC to allow for a clear cut separation of LGFMS from other spindle cell or myxoid lesions, but high-grade sarcoma could be excluded.
  • [MeSH-major] Biopsy, Fine-Needle. Fibroma. Sarcoma. Soft Tissue Neoplasms
  • [MeSH-minor] Adult. Aged. Cytogenetics. Female. Humans. Immunohistochemistry. Male. Middle Aged

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18637810.001).
  • [ISSN] 1365-2303
  • [Journal-full-title] Cytopathology : official journal of the British Society for Clinical Cytology
  • [ISO-abbreviation] Cytopathology
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  •  go-up   go-down


27. Thanakit V, Nelson SD, Udomsawaengsup S: Round cell liposarcoma of scrotum with indolent course in young adult. J Med Assoc Thai; 2005 Sep;88(9):1302-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Round cell liposarcoma of scrotum with indolent course in young adult.
  • Round cell liposarcoma is highly metastatic and is classified as high grade and poorly differentiated myxoid sarcoma.
  • Most masses within the scrotal sac arise from the testis proper, and less likely from the extratesticular tissue.
  • Myxoid/round cell liposarcoma and round cell liposarcoma are rarely encounter in extratesticular soft tissue.
  • We reported a rare case of round cell liposarcoma (high grade myxoid liposarcoma) of extratesticular tissue.
  • To our knowledge, this is the first case of a large size (> 5cm) round cell liposarcoma arising from soft tissue within the scrotal sac of young adult with indolent course.
  • Simple excision or enucleation are inadequate therapies and wide excision of the hemiscrotum including inguinal soft tissue and nodes is recommended.
  • [MeSH-minor] Adult. Diagnosis, Differential. Humans. Male. Prognosis. Scrotum / pathology. Testicular Hydrocele / pathology

  • Genetic Alliance. consumer health - Liposarcoma.
  • MedlinePlus Health Information. consumer health - Testicular Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16536120.001).
  • [ISSN] 0125-2208
  • [Journal-full-title] Journal of the Medical Association of Thailand = Chotmaihet thangphaet
  • [ISO-abbreviation] J Med Assoc Thai
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Thailand
  •  go-up   go-down


28. Lazzaro G, Lazzari R, Pelosi G, De Pas T, Mariani L, Mazzarol G, Sances D, Tosti G, Baldini F, Mosconi M, Tedeschi I, Viale G, Marsiglia H, Chiappa A, Vavassori A, Orecchia R, Testori A: Pulsed dose-rate perioperative interstitial brachytherapy for soft tissue sarcomas of the extremities and skeletal muscles of the trunk. Ann Surg Oncol; 2005 Nov;12(11):935-42
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pulsed dose-rate perioperative interstitial brachytherapy for soft tissue sarcomas of the extremities and skeletal muscles of the trunk.
  • BACKGROUND: This study evaluated the role of pulsed dose-rate (PDR) brachytherapy (BRT), delivered alone or as a boost to external beam radiotherapy, as adjuvant therapy for the local control of soft tissue sarcomas of the extremities and skeletal muscles of the trunk that have undergone surgical treatment.
  • METHODS: Between July 1998 and January 2002, 42 patients were treated with a combination of surgery and BRT alone (18 patients) or BRT/external beam radiotherapy (24 patients) for the treatment of primary (n = 32) and recurrent (n = 10) soft tissue sarcomas located in the proximal extremity (n = 17), distal extremity (n = 17), and trunk (n = 8).
  • CONCLUSIONS: PDR interstitial BRT for soft tissue sarcoma is an effective, well-tolerated adjuvant radiation treatment that offers several practical advantages, among which are low acute and late toxicity with maximum normal tissue and critical structure sparing and overall shorter radiotherapy and hospital stay.
  • [MeSH-major] Brachytherapy. Extremities. Muscle, Skeletal. Sarcoma / radiotherapy. Soft Tissue Neoplasms / radiotherapy
  • [MeSH-minor] Adult. Aged. Female. Follow-Up Studies. Humans. Male. Middle Aged. Radiotherapy Dosage. Radiotherapy, Adjuvant / adverse effects. Radiotherapy, Adjuvant / utilization. Survival Rate

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16195832.001).
  • [ISSN] 1068-9265
  • [Journal-full-title] Annals of surgical oncology
  • [ISO-abbreviation] Ann. Surg. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


29. Maduekwe UN, Hornicek FJ, Springfield DS, Raskin KA, Harmon DC, Choy E, Rosenberg AE, Nielsen GP, DeLaney TF, Chen YL, Ott MJ, Yoon SS: Role of sentinel lymph node biopsy in the staging of synovial, epithelioid, and clear cell sarcomas. Ann Surg Oncol; 2009 May;16(5):1356-63
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Soft tissue sarcomas generally have a </=5% risk of lymph node metastasis, but synovial, epithelioid, and clear cell subtypes reportedly have a much higher risk.
  • The utility of sentinel lymph node biopsy (SLNB) for patients with these sarcoma subtypes is unknown.
  • The histological subtypes were synovial sarcoma in 16 patients, epithelioid sarcoma in 10, and clear cell sarcoma in 3.
  • CONCLUSION: For patients with these sarcoma subtypes without radiological evidence of nodal or distant metastases, the incidence of occult lymph node metastasis is relatively low.
  • [MeSH-major] Sarcoma / pathology. Sarcoma, Clear Cell / pathology. Sarcoma, Synovial / pathology. Sentinel Lymph Node Biopsy
  • [MeSH-minor] Adolescent. Adult. Aged. Child. Extremities. Female. Humans. Male. Middle Aged. Neoplasm Staging. Retrospective Studies. Young Adult

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19259743.001).
  • [ISSN] 1534-4681
  • [Journal-full-title] Annals of surgical oncology
  • [ISO-abbreviation] Ann. Surg. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  •  go-up   go-down


30. Hua C, Gray JM, Merchant TE, Kun LE, Krasin MJ: Treatment planning and delivery of external beam radiotherapy for pediatric sarcoma: the St. Jude Children's Research Hospital experience. Int J Radiat Oncol Biol Phys; 2008 Apr 1;70(5):1598-606
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Treatment planning and delivery of external beam radiotherapy for pediatric sarcoma: the St. Jude Children's Research Hospital experience.
  • PURPOSE: To describe and review the radiotherapy (RT) treatment planning and delivery techniques used for pediatric sarcoma patients at St. Jude Children's Research Hospital.
  • PATIENTS AND METHODS: Since January 2003, we have prospectively treated pediatric and young-adult patients with soft-tissue and bone sarcomas on an institutional Phase II protocol evaluating local control and RT-related treatment effects from external-beam RT (conformal or intensity-modulated RT; 83.4%), low-dose-rate brachytherapy (8.3%), or both (8.3%).
  • Long-term follow-up will determine the risk of local failure and the benefit of normal tissue avoidance for this population.
  • [MeSH-major] Bone Neoplasms / radiotherapy. Sarcoma / radiotherapy. Soft Tissue Neoplasms / radiotherapy
  • [MeSH-minor] Adolescent. Adult. Brachytherapy / methods. Child. Child, Preschool. Female. Humans. Infant. Male. Prospective Studies. Radiotherapy Dosage. Radiotherapy, Conformal / methods. Radiotherapy, Intensity-Modulated. Tennessee. Tumor Burden

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • COS Scholar Universe. author profiles.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18234441.001).
  • [ISSN] 0360-3016
  • [Journal-full-title] International journal of radiation oncology, biology, physics
  • [ISO-abbreviation] Int. J. Radiat. Oncol. Biol. Phys.
  • [Language] eng
  • [Publication-type] Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


31. López-Pousa A, Losa R, Martín J, Maurel J, Fra J, Sierra M, Casado A, García Del Muro J, Poveda A, Balañá C, Martínez-Trufero J, Esteban E, Buesa JM: Phase I/II trial of doxorubicin and fixed dose-rate infusion gemcitabine in advanced soft tissue sarcomas: a GEIS study. Br J Cancer; 2006 Jun 19;94(12):1797-802
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Phase I/II trial of doxorubicin and fixed dose-rate infusion gemcitabine in advanced soft tissue sarcomas: a GEIS study.
  • The aim of the study was to determine the dose-limiting toxicity and maximum tolerated dose of a first-line combination of doxorubicin and gemcitabine in adult patients with advanced soft tissue sarcomas and to explore its activity and toxicity, and the presence of possible interactions between these agents.
  • [MeSH-major] Antineoplastic Combined Chemotherapy Protocols / adverse effects. Sarcoma / drug therapy. Soft Tissue Neoplasms / drug therapy
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Deoxycytidine / administration & dosage. Deoxycytidine / analogs & derivatives. Deoxycytidine / metabolism. Deoxycytidine / pharmacokinetics. Dose-Response Relationship, Drug. Doxorubicin / administration & dosage. Doxorubicin / metabolism. Doxorubicin / pharmacokinetics. Drug Interactions. Female. Humans. Male. Maximum Tolerated Dose. Middle Aged

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • Hazardous Substances Data Bank. DOXORUBICIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Br J Cancer. 1999 Oct;81(4):609-15 [10574245.001]
  • [Cites] Invest New Drugs. 1997;15(4):331-41 [9547676.001]
  • [Cites] Cancer Chemother Pharmacol. 2000;45(2):177-81 [10663634.001]
  • [Cites] J Clin Oncol. 2000 May;18(10):2081-6 [10811673.001]
  • [Cites] J Clin Oncol. 2000 Jul;18(13):2545-52 [10893285.001]
  • [Cites] Anticancer Drugs. 2000 Jun;11(5):325-9 [10912948.001]
  • [Cites] Ann Hematol. 2000 Sep;79(9):485-92 [11043419.001]
  • [Cites] J Clin Oncol. 2001 Aug 1;19(15):3483-9 [11481354.001]
  • [Cites] Semin Oncol. 2001 Jun;28(3 Suppl 10):57-61 [11510035.001]
  • [Cites] Eur J Cancer. 2002 Mar;38(4):556-9 [11872349.001]
  • [Cites] J Clin Oncol. 2002 Jun 15;20(12):2824-31 [12065559.001]
  • [Cites] Ann Oncol. 2002 Jun;13(6):919-27 [12123338.001]
  • [Cites] Ann Oncol. 2002 Nov;13(11):1771-8 [12419750.001]
  • [Cites] Cancer. 2003 Apr 15;97(8):1969-73 [12673725.001]
  • [Cites] Ann Oncol. 1998 Sep;9(9):1003-8 [9818075.001]
  • [Cites] Clin Ter. 1999 Jan-Feb;150(1):17-20 [10367540.001]
  • [Cites] Cancer. 2004 Nov 15;101(10):2261-9 [15484216.001]
  • [Cites] Clin Cancer Res. 2004 Feb 15;10(4):1500-7 [14977854.001]
  • [Cites] J Clin Oncol. 2004 May 1;22(9):1706-12 [15117993.001]
  • [Cites] Clin Cancer Res. 2004 May 1;10(9):2936-43 [15131028.001]
  • [Cites] J Chromatogr. 1988 Jan 22;424(1):103-10 [3163337.001]
  • [Cites] Control Clin Trials. 1989 Mar;10(1):1-10 [2702835.001]
  • [Cites] Cancer. 1990 Sep 1;66(5):862-7 [2201431.001]
  • [Cites] Cancer Chemother Pharmacol. 1991;27(4):258-62 [1998982.001]
  • [Cites] J Clin Oncol. 1991 Mar;9(3):491-8 [1999720.001]
  • [Cites] Ann Oncol. 1994 Jul;5(6):539-42 [7918126.001]
  • [Cites] J Clin Oncol. 1995 Jul;13(7):1537-45 [7602342.001]
  • [Cites] Semin Oncol. 1995 Aug;22(4 Suppl 11):3-10 [7481842.001]
  • [Cites] J Natl Cancer Inst. 2000 Feb 2;92(3):205-16 [10655437.001]
  • (PMID = 16721358.001).
  • [ISSN] 0007-0920
  • [Journal-full-title] British journal of cancer
  • [ISO-abbreviation] Br. J. Cancer
  • [Language] eng
  • [Publication-type] Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0W860991D6 / Deoxycytidine; 80168379AG / Doxorubicin; B76N6SBZ8R / gemcitabine
  • [Other-IDs] NLM/ PMC2361345
  •  go-up   go-down


32. Beltrami G, Rüdiger HA, Mela MM, Scoccianti G, Livi L, Franchi A, Campanacci DA, Capanna R: Limb salvage surgery in combination with brachytherapy and external beam radiation for high-grade soft tissue sarcomas. Eur J Surg Oncol; 2008 Jul;34(7):811-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Limb salvage surgery in combination with brachytherapy and external beam radiation for high-grade soft tissue sarcomas.
  • While combined treatment of high-grade soft tissue sarcoma with resection and radiotherapy has become an accepted standard, outlines of treatment algorithms remain a matter of debate.
  • It was the purpose of this study to determine long-term outcome, prognostic factors for local and systemic recurrence and morbidity in patients with high-grade soft tissue sarcomas of the extremities, who were subjected to this regimen.
  • Using our treatment algorithm for high-grade soft tissue sarcoma of the extremities, good local and systemic control can be achieved with a low complication rate.
  • [MeSH-major] Brachytherapy / methods. Limb Salvage. Sarcoma / radiotherapy. Sarcoma / surgery
  • [MeSH-minor] Adolescent. Adult. Aged. Algorithms. Child. Extremities. Female. Humans. Male. Middle Aged. Neoplasm Recurrence, Local / therapy. Prognosis. Radiotherapy, Adjuvant. Risk Factors. Survival Analysis

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17981427.001).
  • [ISSN] 1532-2157
  • [Journal-full-title] European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
  • [ISO-abbreviation] Eur J Surg Oncol
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] England
  •  go-up   go-down


33. Günay C, Atalar H, Kaygusuz G, Yildiz Y, Sağlik Y: [Alveolar soft part sarcoma of the extremities: an evaluation of four cases]. Acta Orthop Traumatol Turc; 2007 Aug-Oct;41(4):326-31
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Alveolar soft part sarcoma of the extremities: an evaluation of four cases].
  • We presented four patients (3 women, 1 man; mean age 40 years; range 20 to 56 years) who had alveolar soft part sarcoma in the left arm, right elbow, right tibia, and left thigh, respectively.
  • T1- and T2-weighted magnetic resonance images of all the patients showed a soft tissue lesion with hyperintense signal changes and heterogeneous contrast enhancement.
  • [MeSH-major] Sarcoma, Alveolar Soft Part / diagnosis. Soft Tissue Neoplasms / diagnosis
  • [MeSH-minor] Adult. Arm. Diagnosis, Differential. Elbow. Fatal Outcome. Female. Humans. Magnetic Resonance Imaging. Male. Middle Aged. Neoplasm Metastasis. Thigh. Tibia

  • Genetic Alliance. consumer health - Alveolar Soft Part Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18180565.001).
  • [ISSN] 1017-995X
  • [Journal-full-title] Acta orthopaedica et traumatologica turcica
  • [ISO-abbreviation] Acta Orthop Traumatol Turc
  • [Language] tur
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Turkey
  •  go-up   go-down


34. Takenaka S, Naka N, Araki N, Hashimoto N, Ueda T, Yoshioka K, Yoshikawa H, Itoh K: Downregulation of SS18-SSX1 expression in synovial sarcoma by small interfering RNA enhances the focal adhesion pathway and inhibits anchorage-independent growth in vitro and tumor growth in vivo. Int J Oncol; 2010 Apr;36(4):823-31
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Downregulation of SS18-SSX1 expression in synovial sarcoma by small interfering RNA enhances the focal adhesion pathway and inhibits anchorage-independent growth in vitro and tumor growth in vivo.
  • Synovial sarcoma (SS) is an aggressive soft-tissue malignancy characterized by a unique t(X;18) translocation resulting in expression of SS18-SSX fusion protein.
  • [MeSH-major] Cell Proliferation. Focal Adhesions / genetics. Genetic Therapy / methods. Neoplasm Proteins / genetics. Oncogene Proteins, Fusion / genetics. Proto-Oncogene Proteins / genetics. RNA Interference. Repressor Proteins / genetics. Sarcoma, Synovial / therapy
  • [MeSH-minor] Adult. Animals. Calcium-Binding Proteins / metabolism. Cell Adhesion / genetics. Cell Line, Tumor. Cell Shape. Down-Regulation. Gene Expression Profiling. Gene Expression Regulation, Neoplastic. Humans. Male. Mice. Mice, Nude. Myosin-Light-Chain Kinase / metabolism. Recombinant Fusion Proteins / metabolism. Time Factors. Transcription, Genetic. Transfection. Tumor Burden. Xenograft Model Antitumor Assays

  • Genetic Alliance. consumer health - Synovial sarcoma.
  • MedlinePlus Health Information. consumer health - Genes and Gene Therapy.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20198325.001).
  • [ISSN] 1791-2423
  • [Journal-full-title] International journal of oncology
  • [ISO-abbreviation] Int. J. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Calcium-Binding Proteins; 0 / Neoplasm Proteins; 0 / Oncogene Proteins, Fusion; 0 / Proto-Oncogene Proteins; 0 / Recombinant Fusion Proteins; 0 / Repressor Proteins; 0 / SS18 protein, human; 0 / SYT-SSX fusion protein; 164289-47-8 / synovial sarcoma X breakpoint proteins; EC 2.7.11.18 / MYLK protein, human; EC 2.7.11.18 / Myosin-Light-Chain Kinase
  •  go-up   go-down


35. Matsuo T, Sugita T, Shimose S, Kubo T, Ishikawa M, Yasunaga Y, Ochi M: Immunohistochemical expression of promyelocytic leukemia body in soft tissue sarcomas. J Exp Clin Cancer Res; 2008;27:73
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Immunohistochemical expression of promyelocytic leukemia body in soft tissue sarcomas.
  • PML body expression rates of all sarcoma cells were 1.5 +/- 1.8% (range: 0-7.0) in MFH and 1.3 +/- 1.4% (0-5.2) in liposarcoma samples.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Female. Humans. Immunohistochemistry. Male. Middle Aged

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Nature. 2000 Jul 13;406(6792):207-10 [10910364.001]
  • [Cites] Cancer Lett. 2003 May 15;194(2):155-62 [12757973.001]
  • [Cites] Nat Cell Biol. 2000 Oct;2(10):730-6 [11025664.001]
  • [Cites] Cell Death Differ. 2003 Dec;10(12):1290-9 [12934066.001]
  • [Cites] Oncogene. 2004 Apr 12;23(16):2819-24 [15077145.001]
  • [Cites] Am J Pathol. 2004 Aug;165(2):471-80 [15277221.001]
  • [Cites] Genes Chromosomes Cancer. 2004 Oct;41(2):155-62 [15287028.001]
  • [Cites] Nature. 1990 Oct 11;347(6293):558-61 [2170850.001]
  • [Cites] Cell. 1991 Aug 23;66(4):663-74 [1652368.001]
  • [Cites] Cell. 1991 Aug 23;66(4):675-84 [1652369.001]
  • [Cites] EMBO J. 1992 Apr;11(4):1397-407 [1314166.001]
  • [Cites] Proc Natl Acad Sci U S A. 1992 Jun 1;89(11):4840-4 [1317574.001]
  • [Cites] N Engl J Med. 1993 Jul 15;329(3):177-89 [8515790.001]
  • [Cites] Blood. 1994 Jan 1;83(1):10-25 [8274729.001]
  • [Cites] Cancer Res. 1995 Apr 1;55(7):1590-7 [7882370.001]
  • [Cites] EMBO J. 1995 Sep 1;14(17):4240-8 [7556065.001]
  • [Cites] J Cancer Res Clin Oncol. 1995;121(9-10):555-63 [7559736.001]
  • [Cites] J Clin Oncol. 1996 May;14(5):1679-89 [8622088.001]
  • [Cites] Am J Pathol. 1996 Dec;149(6):2023-35 [8952536.001]
  • [Cites] J Clin Oncol. 1997 Jan;15(1):350-62 [8996162.001]
  • [Cites] Nat Med. 1997 Nov;3(11):1271-4 [9359704.001]
  • [Cites] Oncogene. 1998 Jun 4;16(22):2905-13 [9671411.001]
  • [Cites] Am J Hum Genet. 1998 Aug;63(2):297-304 [9683622.001]
  • [Cites] Nat Genet. 1998 Nov;20(3):266-72 [9806545.001]
  • [Cites] Blood. 1999 May 15;93(10):3167-215 [10233871.001]
  • [Cites] Clin Cancer Res. 2005 Jan 1;11(1):217-25 [15671549.001]
  • [Cites] Cancer Res. 2005 Apr 1;65(7):2722-9 [15805271.001]
  • [Cites] Int J Cancer. 2005 Jul 1;115(4):556-60 [15688424.001]
  • [Cites] Cancer Lett. 2006 Jan 18;231(2):176-84 [16399222.001]
  • [Cites] Nature. 2006 Aug 17;442(7104):779-85 [16915281.001]
  • [Cites] Cell Res. 2008 Jun;18(6):622-40 [18504460.001]
  • [Cites] EMBO J. 2000 Nov 15;19(22):6185-95 [11080164.001]
  • [Cites] EMBO J. 2001 Aug 15;20(16):4547-59 [11500381.001]
  • [Cites] Oncogene. 2001 Oct 29;20(49):7257-65 [11704854.001]
  • [Cites] Cell. 2002 Jan 25;108(2):165-70 [11832207.001]
  • [Cites] Differentiation. 2002 Mar;70(1):10-22 [11963652.001]
  • [Cites] EMBO J. 2002 Jul 1;21(13):3358-69 [12093737.001]
  • [Cites] Mol Cell Biol. 2002 Aug;22(15):5259-69 [12101223.001]
  • [Cites] Cancer Cell. 2002 Oct;2(4):257-65 [12398889.001]
  • [Cites] Cancer Res. 2003 Apr 15;63(8):1759-63 [12702558.001]
  • [Cites] Genes Dev. 2000 Aug 15;14(16):2015-27 [10950866.001]
  • (PMID = 19025608.001).
  • [ISSN] 1756-9966
  • [Journal-full-title] Journal of experimental & clinical cancer research : CR
  • [ISO-abbreviation] J. Exp. Clin. Cancer Res.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Italy
  • [Chemical-registry-number] 0 / Nuclear Proteins; 0 / Transcription Factors; 0 / Tumor Suppressor Proteins; 143220-95-5 / PML protein, human
  • [Other-IDs] NLM/ PMC2611968
  •  go-up   go-down


36. da Cunha IW, Kowalski LP, Soares FA: Dedifferentiated liposarcoma of the oral cavity with angiosarcomatous dedifferentiation. Virchows Arch; 2005 Apr;446(4):456-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We report a unique case of a 42-year-old woman with a dedifferentiated liposarcoma of the soft tissue of the oral cavity with angiosarcomatous dedifferentiation.
  • Dedifferentiation in liposarcomas occurs in about 10% of the cases and, when it occurs, the dedifferentiated areas usually resemble high-grade fibrosarcoma or pleomorphic sarcoma.
  • [MeSH-major] Hemangiosarcoma / pathology. Liposarcoma / pathology. Mouth Neoplasms / pathology. Soft Tissue Neoplasms / pathology
  • [MeSH-minor] Adult. Cell Transformation, Neoplastic. Disease-Free Survival. Female. Humans. Radiotherapy, Adjuvant. Treatment Outcome

  • Genetic Alliance. consumer health - Liposarcoma.
  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Head Neck. 1992 Jan-Feb;14(1):1-7 [1624288.001]
  • [Cites] J Otolaryngol. 2002 Apr;31(2):125-8 [12019743.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002 Sep;94(3):333-7 [12324789.001]
  • [Cites] Int J Surg Pathol. 2002 Jan;10(1):75-9 [11927975.001]
  • [Cites] Am J Surg Pathol. 1998 Aug;22(8):945-55 [9706974.001]
  • [Cites] Semin Diagn Pathol. 2001 Nov;18(4):263-6 [11757866.001]
  • [Cites] Mod Pathol. 2002 Oct;15(10):1020-31 [12379747.001]
  • [Cites] Am J Surg Pathol. 1997 Mar;21(3):271-81 [9060596.001]
  • [Cites] Virchows Arch Pathol Anat Physiol Klin Med. 1962;335:367-88 [13890373.001]
  • [Cites] J Clin Periodontol. 2001 Feb;28(2):109-12 [11168734.001]
  • [Cites] Am J Surg Pathol. 1994 Nov;18(11):1150-7 [7943536.001]
  • [Cites] Ann Surg. 1944 Jan;119(1):86-107 [17858339.001]
  • [Cites] Cancer. 1960 Sep-Oct;13:932-50 [13696965.001]
  • [Cites] Ann Diagn Pathol. 2000 Aug;4(4):252-66 [10982304.001]
  • [Cites] J Oral Pathol Med. 1999 Feb;28(2):92-5 [9950257.001]
  • [Cites] Br J Cancer. 1970 Dec;24(4):696-704 [5503596.001]
  • [Cites] Semin Oncol. 1981 Jun;8(2):185-9 [7196088.001]
  • [Cites] Ann Diagn Pathol. 2002 Apr;6(2):83-93 [12004355.001]
  • [Cites] Acta Pathol Jpn. 1982 Nov;32(6):933-48 [6297235.001]
  • [Cites] Am J Surg Pathol. 1994 Dec;18(12):1213-23 [7977944.001]
  • [Cites] Cancer. 1995 Sep 15;76(6):1051-8 [8625207.001]
  • [Cites] Oral Oncol. 2002 Dec;38(8):757-62 [12570054.001]
  • [Cites] Pathol Int. 2000 Jul;50(7):558-61 [10886740.001]
  • (PMID = 15806379.001).
  • [ISSN] 0945-6317
  • [Journal-full-title] Virchows Archiv : an international journal of pathology
  • [ISO-abbreviation] Virchows Arch.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Germany
  • [Number-of-references] 25
  •  go-up   go-down


37. Meng GZ, Zhang HY, Bu H, Zhang XL, Pang ZG, Ke Q, Liu X, Yang G: Myofibroblastic sarcomas: a clinicopathological study of 20 cases. Chin Med J (Engl); 2007 Mar 5;120(5):363-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Myofibroblastic sarcoma was used to be a controversial neoplasm.
  • This study investigated the clinicopathological features of 20 cases of myofibroblastic sarcoma arising in different locations.
  • METHODS: The paraffin-embedded tissue samples from 20 cases of patients with myofibroblastic sarcoma were stained immunohistochemically, and 5 cases examined by electron microscopy.
  • [MeSH-major] Fibrosarcoma / pathology. Myosarcoma / pathology. Soft Tissue Neoplasms / pathology
  • [MeSH-minor] Adolescent. Adult. Child. Desmin / analysis. Female. Humans. Immunohistochemistry. Male. Middle Aged. Recurrence

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17376304.001).
  • [ISSN] 0366-6999
  • [Journal-full-title] Chinese medical journal
  • [ISO-abbreviation] Chin. Med. J.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Desmin
  •  go-up   go-down


38. Seidel C, Bartel F, Rastetter M, Bluemke K, Wurl P, Taubert H, Dammann R: Alterations of cancer-related genes in soft tissue sarcomas: hypermethylation of RASSF1A is frequently detected in leiomyosarcoma and associated with poor prognosis in sarcoma. Int J Cancer; 2005 Apr 10;114(3):442-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Alterations of cancer-related genes in soft tissue sarcomas: hypermethylation of RASSF1A is frequently detected in leiomyosarcoma and associated with poor prognosis in sarcoma.
  • In this study, the methylation status of RASSF1A, p16, MLH1, MSH2 and ERalpha was investigated in 84 primary soft tissue sarcomas (STSs), including 22 liposarcomas, 18 malignant fibrous histiocytomas (MFHs), 18 leiomyosarcomas, 6 rhabdomyosarcomas, 6 neurogenic sarcomas and several other sarcoma entities.
  • In 7 out of 81 (9%) STS samples, the promoter of MLH1 was methylated and in liposarcoma the methylation frequency was higher (14%).
  • Methylation of ERalpha was detected in 48 of 63 (76%) STSs, but also in 4 of 8 (50%) normal tissue samples.
  • In an univariate Cox proportional-hazards regression model, we found that the risk of a tumor-related death for STS patients with methylated RASSF1A was significantly increased (RR = 2.9; p = 0.037).
  • In summary, our data indicate that inactivation of RASSF1A is a common event in STS, especially in leiomyosarcoma.
  • Thus, the methylation status of cancer-related genes was distinct in different STS and methylation of RASSF1A promoter can serve as prognostic marker in STSs.
  • [MeSH-major] DNA Methylation. Leiomyosarcoma / genetics. Leiomyosarcoma / pathology. Sarcoma / genetics. Sarcoma / pathology. Tumor Suppressor Proteins / genetics. Tumor Suppressor Proteins / metabolism
  • [MeSH-minor] Adult. Histiocytoma, Benign Fibrous / genetics. Histiocytoma, Benign Fibrous / pathology. Humans. Liposarcoma / genetics. Liposarcoma / pathology. Prognosis. Promoter Regions, Genetic. Survival Analysis


39. Collins JJ, Bodner K, Aylward LL, Wilken M, Bodnar CM: Mortality rates among trichlorophenol workers with exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Am J Epidemiol; 2009 Aug 15;170(4):501-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • However, for 4 deaths of soft tissue sarcoma (SMR = 4.1, 95% CI: 1.1, 10.5), the mortality rates increased with exposure.
  • With the exception of soft tissue sarcoma, the authors found little evidence of increased disease risk from exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
  • [MeSH-minor] Adult. Case-Control Studies. Cause of Death. Follow-Up Studies. Humans. Michigan / epidemiology. Neoplasms / mortality. Pentachlorophenol / adverse effects. Pentachlorophenol / analysis. Proportional Hazards Models. Risk. Sarcoma / mortality. Soft Tissue Neoplasms / mortality

  • MedlinePlus Health Information. consumer health - Occupational Health.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. Pentachlorophenol .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Ind Health. 2003 Jul;41(3):175-80 [12916747.001]
  • [Cites] Occup Environ Med. 2003 Sep;60(9):672-5 [12937189.001]
  • [Cites] Regul Toxicol Pharmacol. 2003 Dec;38(3):378-88 [14623487.001]
  • [Cites] Environ Health Perspect. 2004 Sep;112(13):1265-8 [15345337.001]
  • [Cites] J Occup Med. 1980 Jan;22(1):11-4 [6444441.001]
  • [Cites] J Occup Med. 1980 Aug;22(8):530-2 [6447199.001]
  • [Cites] J Occup Med. 1987 May;29(5):422-9 [2439670.001]
  • [Cites] J Occup Med. 1989 Sep;31(9):771-4 [2529357.001]
  • [Cites] N Engl J Med. 1991 Jan 24;324(4):212-8 [1985242.001]
  • [Cites] Ann N Y Acad Sci. 1990;609:87-97; discussion 97-9 [2264660.001]
  • [Cites] Epidemiology. 1992 Jan;3(1):65-9 [1554813.001]
  • [Cites] Epidemiology. 1993 Jan;4(1):14-9 [8420575.001]
  • [Cites] Epidemiology. 1993 Jan;4(1):7-13 [8420584.001]
  • [Cites] Am J Ind Med. 1993 Feb;23(2):289-300 [8427257.001]
  • [Cites] Am J Epidemiol. 1995 Dec 1;142(11):1165-75 [7485063.001]
  • [Cites] J Toxicol Environ Health. 1996 Mar;47(4):363-78 [8600289.001]
  • [Cites] Cancer Causes Control. 1996 May;7(3):312-21 [8734824.001]
  • [Cites] Occup Environ Med. 1996 Sep;53(9):606-12 [8882118.001]
  • [Cites] Am J Epidemiol. 1997 Jun 15;145(12):1061-75 [9199536.001]
  • [Cites] IARC Monogr Eval Carcinog Risks Hum. 1997;69:1-631 [9379504.001]
  • [Cites] J Occup Environ Med. 1998 Apr;40(4):351-62 [9571527.001]
  • [Cites] Am J Epidemiol. 1998 May 1;147(9):891-901 [9583720.001]
  • [Cites] Environ Health Perspect. 1998 Apr;106 Suppl 2:655-62 [9599713.001]
  • [Cites] J Natl Cancer Inst. 1999 May 5;91(9):779-86 [10328108.001]
  • [Cites] Mil Med. 2005 May;170(5):406-13 [15974208.001]
  • [Cites] Risk Anal. 2006 Aug;26(4):1059-71 [16948697.001]
  • [Cites] J Expo Sci Environ Epidemiol. 2007 Sep;17(6):541-8 [17426737.001]
  • [Cites] J Occup Environ Med. 2008 Mar;50(3):330-40 [18332783.001]
  • [Cites] Am J Epidemiol. 2008 Apr 1;167(7):847-58 [18192277.001]
  • [CommentIn] Am J Epidemiol. 2010 Jan 1;171(1):129-30; author reply 130-1 [19995829.001]
  • (PMID = 19561065.001).
  • [ISSN] 1476-6256
  • [Journal-full-title] American journal of epidemiology
  • [ISO-abbreviation] Am. J. Epidemiol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Chlorophenols; 0 / Dioxins; 04PL7F455E / 2,3,7,8-tetrabromodibenzo-4-dioxin; D9BSU0SE4T / Pentachlorophenol
  • [Other-IDs] NLM/ PMC2717168
  •  go-up   go-down


40. Moretti VM, Brooks JS, Ogilvie CM: Case report: hemosiderotic fibrohistiocytic lipomatous lesion: a clinicopathologic characterization. Clin Orthop Relat Res; 2010 Oct;468(10):2808-13
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Hemosiderosis / pathology. Histiocytic Disorders, Malignant / pathology. Lipoma / pathology. Soft Tissue Neoplasms / pathology
  • [MeSH-minor] Adult. Aged. Female. Foot. Humans. Magnetic Resonance Imaging. Male. Middle Aged. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Mod Pathol. 2000 Nov;13(11):1192-9 [11106076.001]
  • [Cites] AJR Am J Roentgenol. 2004 Mar;182(3):733-9 [14975977.001]
  • [Cites] Am J Surg Pathol. 2004 Nov;28(11):1417-25 [15489645.001]
  • [Cites] Skeletal Radiol. 1997 Mar;26(3):150-4 [9108224.001]
  • [Cites] J Pathol. 2009 Apr;217(5):716-27 [19199331.001]
  • [Cites] Histopathology. 2006 Mar;48(4):453-61 [16487368.001]
  • [Cites] Pathol Int. 2006 May;56(5):283-6 [16669878.001]
  • [Cites] Skeletal Radiol. 2008 Jan;37(1):71-4 [17968543.001]
  • [Cites] Cancer Genet Cytogenet. 2008 Apr 15;182(2):140-3 [18406878.001]
  • [Cites] Virchows Arch. 2005 Jul;447(1):103-6 [15947948.001]
  • (PMID = 20127213.001).
  • [ISSN] 1528-1132
  • [Journal-full-title] Clinical orthopaedics and related research
  • [ISO-abbreviation] Clin. Orthop. Relat. Res.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 11
  • [Other-IDs] NLM/ PMC3049609
  •  go-up   go-down


41. Cherix S, Speiser M, Matter M, Raffoul W, Liénard D, Theumann N, Mouhsine E, Mirimanoff RO, Leyvraz S, Lejeune FJ, Leyvraz PF: Isolated limb perfusion with tumor necrosis factor and melphalan for non-resectable soft tissue sarcomas: long-term results on efficacy and limb salvage in a selected group of patients. J Surg Oncol; 2008 Sep 1;98(3):148-55
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Isolated limb perfusion with tumor necrosis factor and melphalan for non-resectable soft tissue sarcomas: long-term results on efficacy and limb salvage in a selected group of patients.
  • BACKGROUND AND OBJECTIVES: Isolated limb perfusion with TNF-alpha and melphalan (TM-ILP) is a limb salvage therapy for non-resectable soft tissue sarcomas (STS) of the extremities.
  • CONCLUSIONS: TM-ILP is a conservative treatment with a high complications rate, but it can be successful even for the most severe STS of extremities.
  • [MeSH-major] Antineoplastic Agents, Alkylating / administration & dosage. Chemotherapy, Cancer, Regional Perfusion. Limb Salvage. Melphalan / administration & dosage. Sarcoma / drug therapy. Soft Tissue Neoplasms / drug therapy. Tumor Necrosis Factor-alpha / administration & dosage
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Female. Humans. Male. Middle Aged. Neoplasm Recurrence, Local / diagnosis. Neoplasm Recurrence, Local / drug therapy. Remission Induction. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • Hazardous Substances Data Bank. MELPHALAN .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18668638.001).
  • [ISSN] 1096-9098
  • [Journal-full-title] Journal of surgical oncology
  • [ISO-abbreviation] J Surg Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Alkylating; 0 / Tumor Necrosis Factor-alpha; Q41OR9510P / Melphalan
  •  go-up   go-down


42. Srivastava A, Rosenberg AE, Selig M, Rubin BP, Nielsen GP: Keratin-positive Ewing's sarcoma: an ultrastructural study of 12 cases. Int J Surg Pathol; 2005 Jan;13(1):43-50
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Keratin-positive Ewing's sarcoma: an ultrastructural study of 12 cases.
  • Ewing's sarcoma/primitive neuroectodermal tumor (EWS/PNET) is an aggressive neoplasm of bone and soft tissue.
  • [MeSH-major] Bone Neoplasms / ultrastructure. Keratins. Neuroectodermal Tumors, Primitive, Peripheral / ultrastructure. Sarcoma, Ewing / ultrastructure. Soft Tissue Neoplasms / ultrastructure
  • [MeSH-minor] Adolescent. Adult. Biomarkers, Tumor / analysis. Child. Fatal Outcome. Female. Humans. Immunohistochemistry. Male. Microscopy, Electron, Transmission. Oncogene Proteins, Fusion / genetics. Proto-Oncogene Protein c-fli-1. RNA, Neoplasm / analysis. RNA-Binding Protein EWS. Reverse Transcriptase Polymerase Chain Reaction. Transcription Factors / genetics

  • Genetic Alliance. consumer health - Ewing's Sarcoma.
  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15735854.001).
  • [ISSN] 1066-8969
  • [Journal-full-title] International journal of surgical pathology
  • [ISO-abbreviation] Int. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / EWS-FLI fusion protein; 0 / Oncogene Proteins, Fusion; 0 / Proto-Oncogene Protein c-fli-1; 0 / RNA, Neoplasm; 0 / RNA-Binding Protein EWS; 0 / Transcription Factors; 68238-35-7 / Keratins
  •  go-up   go-down


43. Bedre G, Gupta T, Rajasekharan P, Munshi A, Jalali R: Cerebellar, pancreatic, and paraspinal metastases in soft tissue sarcomas: unusual sites or changing patterns? JOP; 2007;8(4):444-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cerebellar, pancreatic, and paraspinal metastases in soft tissue sarcomas: unusual sites or changing patterns?
  • CONTEXT: Soft tissue sarcomas generally first metastasize to the lungs followed by the involvement of other sites such as lymph nodes and bones as part of the disseminated disease.
  • Cerebellar and pancreatic metastases from tumors of mesenchymal origin such as soft tissue sarcomas are exceptional, more so in the absence of pulmonary metastases.
  • CASE REPORT: A previously treated case of chest wall sarcoma presented with the sudden onset of neurological symptoms.
  • A metastasectomy of the solitary brain lesion confirmed a deposit from a previously treated sarcoma.
  • A CT-guided biopsy was suggestive of high-grade sarcoma.
  • CONCLUSION: Cerebellar, pancreatic, and paraspinal metastases from soft tissue sarcomas are rare, especially in the absence of pulmonary metastases.
  • [MeSH-major] Cerebellar Neoplasms / secondary. Pancreatic Neoplasms / secondary. Sarcoma / pathology. Soft Tissue Neoplasms / pathology. Spinal Neoplasms / secondary
  • [MeSH-minor] Adult. Humans. Male

  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17625297.001).
  • [ISSN] 1590-8577
  • [Journal-full-title] JOP : Journal of the pancreas
  • [ISO-abbreviation] JOP
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


44. Tran PT, Hara W, Su Z, Lin HJ, Bendapudi PK, Norton J, Teng N, King CR, Kapp DS: Intraoperative radiation therapy for locally advanced and recurrent soft-tissue sarcomas in adults. Int J Radiat Oncol Biol Phys; 2008 Nov 15;72(4):1146-53
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intraoperative radiation therapy for locally advanced and recurrent soft-tissue sarcomas in adults.
  • PURPOSE: To analyze the outcomes of and identify prognostic factors for patients treated with surgery and intraoperative radiotherapy (IORT) for locally advanced and recurrent soft-tissue sarcoma in adults from a single institution.
  • [MeSH-major] Neoplasm Recurrence, Local / radiotherapy. Neoplasm Recurrence, Local / surgery. Sarcoma / radiotherapy. Sarcoma / surgery. Soft Tissue Neoplasms / radiotherapy. Soft Tissue Neoplasms / surgery
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. California / epidemiology. Humans. Incidence. Intraoperative Care / methods. Male. Middle Aged. Radiotherapy, Adjuvant. Retrospective Studies. Survival Analysis. Survival Rate

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18394818.001).
  • [ISSN] 1879-355X
  • [Journal-full-title] International journal of radiation oncology, biology, physics
  • [ISO-abbreviation] Int. J. Radiat. Oncol. Biol. Phys.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


45. Adkison JB, Kuske RR, Patel RR: Breast conserving surgery and accelerated partial breast irradiation after prior breast radiation therapy. Am J Clin Oncol; 2010 Oct;33(5):427-31
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Six patients were previously treated for Hodgkin disease, 4 for invasive or in situ breast cancer, and 1 for soft tissue sarcoma.
  • [MeSH-minor] Adult. Aged. Female. Humans. Middle Aged. Patient Satisfaction. Radiotherapy, Computer-Assisted. Recurrence. Reoperation. Survival Analysis

  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19884802.001).
  • [ISSN] 1537-453X
  • [Journal-full-title] American journal of clinical oncology
  • [ISO-abbreviation] Am. J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


46. Llácer C, Delannes M, Minsat M, Stoeckle E, Votron L, Martel P, Bonnevialle P, Nguyen Bui B, Chevreau C, Kantor G, Daly-Schveitzer N, Thomas L: Low-dose intraoperative brachytherapy in soft tissue sarcomas involving neurovascular structure. Radiother Oncol; 2006 Jan;78(1):10-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Low-dose intraoperative brachytherapy in soft tissue sarcomas involving neurovascular structure.
  • BACKGROUND AND PURPOSE: To evaluate intraoperative brachytherapy in the management of soft tissue sarcomas involving neurovascular structures, its impact on local control and complications.
  • CONCLUSIONS: Intraoperative brachytherapy is efficient with excellent local control rates in soft tissue sarcomas presenting with neurovascular involvement and offers an acceptable conservative option.
  • [MeSH-major] Brachytherapy. Sarcoma / radiotherapy. Soft Tissue Neoplasms / radiotherapy
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Combined Modality Therapy. Female. Follow-Up Studies. Humans. Intraoperative Period. Iridium Radioisotopes / therapeutic use. Male. Middle Aged. Survival Analysis

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16376446.001).
  • [ISSN] 0167-8140
  • [Journal-full-title] Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
  • [ISO-abbreviation] Radiother Oncol
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] Ireland
  • [Chemical-registry-number] 0 / Iridium Radioisotopes
  •  go-up   go-down


47. Cranshaw IM, Gikas PD, Fisher C, Thway K, Thomas JM, Hayes AJ: Clinical outcomes of extra-thoracic solitary fibrous tumours. Eur J Surg Oncol; 2009 Sep;35(9):994-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Those tumours with atypical or malignant features on histological examination have poor prognosis and should be managed and followed up in the same manner as other high-grade soft tissue tumours.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Female. Humans. London. Male. Middle Aged. Neoplasm Recurrence, Local. Retrospective Studies. Survival Analysis. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19345055.001).
  • [ISSN] 1532-2157
  • [Journal-full-title] European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
  • [ISO-abbreviation] Eur J Surg Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


48. Watts AC, Teoh K, Evans T, Beggs I, Robb J, Porter D: MRI surveillance after resection for primary musculoskeletal sarcoma. J Bone Joint Surg Br; 2008 Apr;90(4):484-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] MRI surveillance after resection for primary musculoskeletal sarcoma.
  • This study reports the experience of one treatment centre with routine surveillance MRI following excision of musculoskeletal sarcoma.
  • A total of 47 patients had a diagnosis of soft-tissue sarcoma and ten of a primary bone tumour.
  • Surveillance scanning has a role in the early detection of local recurrence of bone and soft-tissue sarcoma.
  • [MeSH-major] Bone Neoplasms / radiography. Magnetic Resonance Imaging. Neoplasm Recurrence, Local / radiography. Sarcoma / radiography. Soft Tissue Neoplasms / radiography
  • [MeSH-minor] Adolescent. Adult. Aged. Child. Early Diagnosis. Female. Humans. Male. Middle Aged. Postoperative Period. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18378924.001).
  • [ISSN] 0301-620X
  • [Journal-full-title] The Journal of bone and joint surgery. British volume
  • [ISO-abbreviation] J Bone Joint Surg Br
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] England
  •  go-up   go-down


49. Nielsen OS, Reichardt P, Christensen TB, Pink D, Daugaard S, Hermans C, Marreaud S, van Glabbeke M, Blay J, Judson I: Phase 1 European Organisation for Research and Treatment of Cancer study determining safety of pegylated liposomal doxorubicin (Caelyx) in combination with ifosfamide in previously untreated adult patients with advanced or metastatic soft tissue sarcomas. Eur J Cancer; 2006 Sep;42(14):2303-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Phase 1 European Organisation for Research and Treatment of Cancer study determining safety of pegylated liposomal doxorubicin (Caelyx) in combination with ifosfamide in previously untreated adult patients with advanced or metastatic soft tissue sarcomas.
  • This phase I study evaluated the toxicity of first-line combined pegylated liposomal doxorubicin (Caelyx) and ifosfamide in patients with advanced and/or metastatic soft tissue sarcomas.
  • In conclusion, this seems to be a feasible combination in patients with advanced soft tissue sarcomas, allowing ifosfamide to be given in a dosage similar to that used when given alone.
  • [MeSH-major] Antineoplastic Combined Chemotherapy Protocols / administration & dosage. Sarcoma / drug therapy
  • [MeSH-minor] Adolescent. Adult. Aged. Dose-Response Relationship, Drug. Doxorubicin / administration & dosage. Doxorubicin / adverse effects. Female. Humans. Ifosfamide / administration & dosage. Ifosfamide / adverse effects. Male. Middle Aged. Neoplasm Metastasis. Treatment Outcome

  • Genetic Alliance. consumer health - Metastatic cancer.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. DOXORUBICIN .
  • Hazardous Substances Data Bank. IFOSFAMIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16891112.001).
  • [ISSN] 0959-8049
  • [Journal-full-title] European journal of cancer (Oxford, England : 1990)
  • [ISO-abbreviation] Eur. J. Cancer
  • [Language] eng
  • [Publication-type] Clinical Trial, Phase I; Journal Article; Multicenter Study
  • [Publication-country] England
  • [Chemical-registry-number] 80168379AG / Doxorubicin; UM20QQM95Y / Ifosfamide
  •  go-up   go-down


50. Liu HY, Yin HL, DU J, Cai Y, Lu ZF, Zhou HB, Zhou XJ: [Clinicopathologic features of granulocytic sarcoma: a study of 38 cases]. Zhonghua Bing Li Xue Za Zhi; 2010 Mar;39(3):172-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Clinicopathologic features of granulocytic sarcoma: a study of 38 cases].
  • OBJECTIVE: To study the clinicopathologic features of granulocytic sarcoma.
  • METHODS: The clinical and pathologic findings of 38 cases of granulocytic sarcoma were retrospectively analyzed.
  • Major clinical presentations included superficial lymph node enlargement and painful soft tissue mass.
  • CONCLUSIONS: Granulocytic sarcoma is a known histologic mimicker of non-Hodgkin lymphoma, Ewing sarcoma/PNET and embryonal rhabdomyosarcoma.
  • [MeSH-major] Muscle Neoplasms / pathology. Ovarian Neoplasms / pathology. Sarcoma, Myeloid / pathology. Skin Neoplasms / pathology
  • [MeSH-minor] Adolescent. Adult. Aged. Antigens, CD43 / metabolism. Burkitt Lymphoma / metabolism. Burkitt Lymphoma / pathology. Child. Child, Preschool. Diagnosis, Differential. Female. Follow-Up Studies. Humans. Lymph Nodes / pathology. Male. Middle Aged. Peroxidase / metabolism. Precursor Cell Lymphoblastic Leukemia-Lymphoma / metabolism. Precursor Cell Lymphoblastic Leukemia-Lymphoma / pathology. Retrospective Studies. Sarcoma, Ewing / metabolism. Sarcoma, Ewing / pathology. Survival Rate. Young Adult

  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20450763.001).
  • [ISSN] 0529-5807
  • [Journal-full-title] Zhonghua bing li xue za zhi = Chinese journal of pathology
  • [ISO-abbreviation] Zhonghua Bing Li Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Antigens, CD43; EC 1.11.1.7 / Peroxidase
  •  go-up   go-down


51. Folk GS, Williams SB, Foss RB, Fanburg-Smith JC: Oral and maxillofacial sclerosing epithelioid fibrosarcoma: report of five cases. Head Neck Pathol; 2007 Sep;1(1):13-20
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Sclerosing epithelioid fibrosarcoma (SEF) has distinctive morphology and occurs mainly in deep soft tissue of adult extremities.
  • Inclusion required OMFR location, an abundantly sclerotic sarcoma with epithelioid features, and lack of other phenotype by immunohistochemistry.
  • Tumor location included the infra-temporal fossa, buccal mucosa (recurrence extending into bone), anterior mandible (intraosseous primary, focally extending into soft tissue), and left parotid and submandibular gland (with metaplastic bone) regions.
  • [MeSH-major] Facial Bones / pathology. Fibrosarcoma / pathology. Maxilla / pathology. Mouth Neoplasms / pathology. Soft Tissue Neoplasms / pathology
  • [MeSH-minor] Adult. Apoptosis. Biomarkers, Tumor / metabolism. Diagnosis, Differential. Epithelioid Cells / metabolism. Epithelioid Cells / pathology. Female. Histiocytoma, Benign Fibrous / diagnosis. Humans. Leiomyoma / diagnosis. Male. Middle Aged. Sclerosis. Solitary Fibrous Tumors / diagnosis. Young Adult

  • Genetic Alliance. consumer health - Fibrosarcoma.
  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer Genet Cytogenet. 2000 Jun;119(2):127-31 [10867148.001]
  • [Cites] Cancer. 1989 Aug 15;64(4):925-31 [2545330.001]
  • [Cites] Am J Surg Pathol. 2001 Jun;25(6):699-709 [11395547.001]
  • [Cites] Am J Surg Pathol. 2002 Sep;26(9):1175-83 [12218574.001]
  • [Cites] Int J Surg Pathol. 2002 Jul;10(3):227-30 [12232581.001]
  • [Cites] J Clin Pathol. 2004 Jan;57(1):90-4 [14693846.001]
  • [Cites] Cancer Genet Cytogenet. 2004 Jul 15;152(2):136-40 [15262433.001]
  • [Cites] Virchows Arch. 2004 Oct;445(4):410-3 [15322876.001]
  • [Cites] Neurosurgery. 2000 Oct;47(4):956-9; discussion 959-60 [11014436.001]
  • [Cites] Methods Enzymol. 1990;184:357-63 [1697021.001]
  • [Cites] Am J Surg Pathol. 1995 Sep;19(9):979-93 [7661286.001]
  • [Cites] Histopathology. 1996 May;28(5):451-5 [8735721.001]
  • [Cites] J Clin Oncol. 1997 Jan;15(1):350-62 [8996162.001]
  • [Cites] Histopathology. 1998 Oct;33(4):354-60 [9822926.001]
  • [Cites] Cancer Genet Cytogenet. 1998 Dec;107(2):102-6 [9844602.001]
  • [Cites] Ann Otol Rhinol Laryngol. 2005 Feb;114(2):87-9 [15757185.001]
  • [ErratumIn] Head Neck Pathol. 2013 Mar;7(1):103
  • (PMID = 20614275.001).
  • [ISSN] 1936-0568
  • [Journal-full-title] Head and neck pathology
  • [ISO-abbreviation] Head Neck Pathol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  • [Other-IDs] NLM/ PMC2807507
  • [Keywords] NOTNLM ; Maxillofacial / Oral / Sarcoma / Sclerosing epithelioid fibrosarcoma
  •  go-up   go-down


52. Aranha O, Agulnik M: Molecularly targeted therapies in adult soft tissue sarcomas: present approach and future directions. Expert Opin Ther Targets; 2008 Feb;12(2):197-207
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Molecularly targeted therapies in adult soft tissue sarcomas: present approach and future directions.
  • Given the overwhelming chemotherapy resistance of the disease, patients with progressive and metastatic soft tissue sarcomas are ideal candidates for trials of investigational new drugs.
  • OBJECTIVE: The authors review the molecular mechanisms underlying soft tissue sarcomas and discuss molecularly targeted therapies developed to improve the poor outcome of these uncommon tumors.
  • METHODS: A Medline and American Society of Clinical Oncology abstract search was conducted using the keyword 'soft tissue sarcoma'.
  • Articles and abstracts were reviewed and eligible for inclusion if they used targeted therapies for the treatment of patients with soft tissue sarcomas.
  • RESULTS/CONCLUSION: Phase II clinical trials for patients with soft tissue sarcomas using novel targets and present recognized targets are ongoing and planned.
  • [MeSH-major] Antineoplastic Agents / pharmacology. Antineoplastic Agents / therapeutic use. Drug Delivery Systems / methods. Sarcoma / drug therapy. Soft Tissue Neoplasms / drug therapy
  • [MeSH-minor] Adult. Humans

  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18208368.001).
  • [ISSN] 1744-7631
  • [Journal-full-title] Expert opinion on therapeutic targets
  • [ISO-abbreviation] Expert Opin. Ther. Targets
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antineoplastic Agents
  • [Number-of-references] 80
  •  go-up   go-down


53. Borinstein SC, Pollard J, Winter L, Hawkins DS: Pegfilgrastim for prevention of chemotherapy-associated neutropenia in pediatric patients with solid tumors. Pediatr Blood Cancer; 2009 Sep;53(3):375-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Primary diagnoses included osteosarcoma, Ewing sarcoma, rhabdomyosarcoma, soft tissue sarcoma, neuroblastoma, Hodgkin disease, and other solid tumors.
  • Eight patients were treated with interval-compressed (every 14 days) sarcoma chemotherapy.
  • [MeSH-minor] Adolescent. Adult. Bone Marrow / drug effects. Child. Child, Preschool. Female. Filgrastim. Health Care Costs. Humans. Infant. Male. Recombinant Proteins. Retrospective Studies

  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • MedlinePlus Health Information. consumer health - Cancer in Children.
  • Hazardous Substances Data Bank. Filgrastim .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2009 Wiley-Liss, Inc.
  • (PMID = 19484756.001).
  • [ISSN] 1545-5017
  • [Journal-full-title] Pediatric blood & cancer
  • [ISO-abbreviation] Pediatr Blood Cancer
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / 2T32CA009351; United States / NCI NIH HHS / CA / 5K12CA076930-08
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Recombinant Proteins; 143011-72-7 / Granulocyte Colony-Stimulating Factor; 3A58010674 / pegfilgrastim; PVI5M0M1GW / Filgrastim
  •  go-up   go-down


54. Tajino T, Kikuchi S, Yamada H, Takeda A, Konno S: Ifosfamide encephalopathy associated with chemotherapy for musculoskeletal sarcomas: incidence, severity, and risk factors. J Orthop Sci; 2010 Jan;15(1):104-11
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Although it has been reported in European and American patients with various carcinomas, there have been no published reports regarding ifosfamide encephalopathy in Asian patients with bone and soft tissue sarcomas.
  • METHODS: We retrospectively examined the incidence, severity, and risk factors of ifosfamide encephalopathy in 61 Japanese patients with bone and soft tissue sarcomas at our institution.
  • [MeSH-major] Antineoplastic Agents, Alkylating / adverse effects. Bone Neoplasms / drug therapy. Ifosfamide / adverse effects. Muscle Neoplasms / drug therapy. Neurotoxicity Syndromes / epidemiology. Sarcoma / drug therapy
  • [MeSH-minor] Adolescent. Adult. Aged. Child. Cisplatin / adverse effects. Dose-Response Relationship, Drug. Drug Synergism. Female. Humans. Incidence. Japan / epidemiology. Male. Middle Aged. Retrospective Studies. Risk Factors. Young Adult

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • Hazardous Substances Data Bank. CIS-DIAMINEDICHLOROPLATINUM .
  • Hazardous Substances Data Bank. IFOSFAMIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20151259.001).
  • [ISSN] 1436-2023
  • [Journal-full-title] Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association
  • [ISO-abbreviation] J Orthop Sci
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Alkylating; Q20Q21Q62J / Cisplatin; UM20QQM95Y / Ifosfamide
  •  go-up   go-down


55. Bay JO, Ray-Coquard I, Fayette J, Leyvraz S, Cherix S, Piperno-Neumann S, Chevreau C, Isambert N, Brain E, Emile G, Le Cesne A, Cioffi A, Kwiatkowski F, Coindre JM, Bui NB, Peyrade F, Penel N, Blay JY, Groupe Sarcome Français: Docetaxel and gemcitabine combination in 133 advanced soft-tissue sarcomas: a retrospective analysis. Int J Cancer; 2006 Aug 1;119(3):706-11
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Docetaxel and gemcitabine combination in 133 advanced soft-tissue sarcomas: a retrospective analysis.
  • Advanced soft-tissue sarcomas are usually resistant to cytotoxic agents such as doxorubicin and ifosfamide.
  • We conducted a retrospective study on 133 patients (58 males/75 females) with unresectable or metastatic soft-tissue sarcoma.
  • No difference was found between uterine soft-tissue sarcomas versus others.
  • [MeSH-major] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Sarcoma / drug therapy
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Analysis of Variance. Deoxycytidine / administration & dosage. Deoxycytidine / adverse effects. Deoxycytidine / analogs & derivatives. Diarrhea / chemically induced. Drug Administration Schedule. Female. Humans. Leiomyosarcoma / drug therapy. Leiomyosarcoma / pathology. Male. Middle Aged. Nausea / chemically induced. Neutropenia / chemically induced. Retrospective Studies. Survival Analysis. Taxoids / administration & dosage. Taxoids / adverse effects. Thrombocytopenia / chemically induced. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • Hazardous Substances Data Bank. DOCETAXEL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2006 Wiley-Liss, Inc.
  • [ErratumIn] Int J Cancer. 2007 Jan 15;120(2):450. Penel, Nicolas [added]
  • (PMID = 16496406.001).
  • [ISSN] 0020-7136
  • [Journal-full-title] International journal of cancer
  • [ISO-abbreviation] Int. J. Cancer
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Taxoids; 0W860991D6 / Deoxycytidine; 15H5577CQD / docetaxel; B76N6SBZ8R / gemcitabine
  •  go-up   go-down


56. Aisner SC, Beebe K, Blacksin M, Mirani N, Hameed M: Primary alveolar soft part sarcoma of fibula demonstrating ASPL-TFE3 fusion: a case report and review of the literature. Skeletal Radiol; 2008 Nov;37(11):1047-51
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary alveolar soft part sarcoma of fibula demonstrating ASPL-TFE3 fusion: a case report and review of the literature.
  • Alveolar soft part sarcoma is a rare soft tissue tumor typically affecting young adults.
  • These tumors are most often seen in the deep soft tissues of the extremities and patients generally present with advanced disease.
  • This is the first case of alveolar soft part sarcoma in bone documenting the ASPL-TFE3 gene product.
  • Herein, we report a rare presentation of alveolar soft part sarcoma presenting as a primary bone neoplasm involving the proximal fibula in a 41-year-old woman.
  • [MeSH-major] Fibula / pathology. Sarcoma, Alveolar Soft Part / diagnosis
  • [MeSH-minor] Adult. Basic Helix-Loop-Helix Leucine Zipper Transcription Factors. Diagnosis, Differential. Female. Humans. Magnetic Resonance Imaging. Oncogene Proteins, Fusion. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Alveolar Soft Part Sarcoma.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Skeletal Radiol. 2000 Dec;29(12 ):680-9 [11271548.001]
  • [Cites] Skeletal Radiol. 1993;22(5):386-9 [8372371.001]
  • [Cites] J Orthop Sci. 2005 Nov;10 (6):652-5 [16307193.001]
  • [Cites] AJR Am J Roentgenol. 1989 Aug;153(2):335-9 [2750619.001]
  • [Cites] Adv Anat Pathol. 1999 May;6(3):125-39 [10342010.001]
  • [Cites] Skeletal Radiol. 1996 May;25(4):400-2 [8738010.001]
  • [Cites] Am J Clin Pathol. 1990 Jan;93(1):32-8 [2403741.001]
  • [Cites] Radiology. 1989 Sep;172(3):827-32 [2772196.001]
  • [Cites] Am J Surg Pathol. 2003 Jun;27(6):750-61 [12766578.001]
  • [Cites] Oncogene. 2001 Jan 4;20(1):48-57 [11244503.001]
  • [Cites] Am J Surg Pathol. 1991 Oct;15(10):974-81 [1656801.001]
  • [Cites] Cancer. 1989 Jan 1;63(1):1-13 [2642727.001]
  • [Cites] Histopathology. 1999 Nov;35(5):411-7 [10583555.001]
  • [Cites] J Bone Joint Surg Am. 1969 Jan;51(1):185-90 [5762710.001]
  • [Cites] Genes Chromosomes Cancer. 1998 Oct;23(2):194-7 [9739024.001]
  • [Cites] Clin Orthop Relat Res. 1993 Sep;(294):259-66 [8358926.001]
  • [Cites] Cancer. 1964 Jul;17:821-30 [14179547.001]
  • [Cites] Am J Surg Pathol. 2007 Aug;31(8):1149-60 [17667536.001]
  • [Cites] Cancer. 1952 Jan;5(1):100-11 [14886902.001]
  • (PMID = 18594808.001).
  • [ISSN] 0364-2348
  • [Journal-full-title] Skeletal radiology
  • [ISO-abbreviation] Skeletal Radiol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / ASPSCR1 protein, human; 0 / Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; 0 / Oncogene Proteins, Fusion; 0 / TFE3 protein, human
  • [Number-of-references] 23
  •  go-up   go-down


57. Al-Hussaini M, Hirschowitz L, McCluggage WG: Uterine neoplasms composed of rhabdoid cells do not exhibit loss of INI1 immunoreactivity and are not related to childhood malignant rhabdoid tumor. Int J Gynecol Pathol; 2008 Apr;27(2):236-42
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Malignant rhabdoid tumors are rare childhood neoplasms which occur most commonly in the kidneys, soft tissue, and central nervous system.
  • In this study, we stained a series of adult uterine neoplasms with a prominent component of rhabdoid cells with the Baf 47 antibody which detects INI1; we aimed to ascertain whether these are related to childhood malignant rhabdoid tumor.
  • Neoplasms included were an undifferentiated sarcoma consisting entirely of rhabdoid cells, 2 carcinosarcomas with a mesenchymal component composed entirely of rhabdoid cells, and 3 uterine tumors resembling ovarian sex cord tumor with rhabdoid cells.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Diagnosis, Differential. Female. Gene Deletion. Gene Expression Regulation, Neoplastic. Humans. Middle Aged. Mutation / genetics. Phenotype. Retrospective Studies

  • Genetic Alliance. consumer health - Rhabdoid tumor.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18317218.001).
  • [ISSN] 1538-7151
  • [Journal-full-title] International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
  • [ISO-abbreviation] Int. J. Gynecol. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Chromosomal Proteins, Non-Histone; 0 / DNA-Binding Proteins; 0 / SMARCB1 protein, human; 0 / Transcription Factors
  •  go-up   go-down


58. Collin T, Blackburn AV, Milner RH, Gerrand C, Ragbir M: Sarcomas in the groin and inguinal canal--often missed and difficult to manage. Ann R Coll Surg Engl; 2010 May;92(4):326-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • INTRODUCTION: This is a 7-year retrospective review summarising the North of England Bone and Soft Tissue Tumour Service's experience of managing 13 cases of groin sarcoma requiring soft tissue flap reconstruction.
  • This study was performed to try to identify where national referral guidelines in sarcoma management had been followed and reasons for any delays.
  • PATIENTS AND METHODS: A retrospective, case-note review was undertaken using the local sarcoma database to identify appropriate patients.
  • [MeSH-major] Groin / surgery. Inguinal Canal / surgery. Sarcoma / surgery. Soft Tissue Neoplasms / surgery
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Female. Guideline Adherence / statistics & numerical data. Humans. Male. Middle Aged. Practice Guidelines as Topic. Reconstructive Surgical Procedures / methods. Referral and Consultation / standards. Retrospective Studies. Surgical Flaps. Treatment Outcome. Young Adult

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Am Coll Surg. 2001 Aug;193(2):130-6 [11491442.001]
  • [Cites] Ann Surg Oncol. 2004 May;11(5):476-82 [15078635.001]
  • [Cites] Surgery. 1974 Mar;75(3):436-41 [4811340.001]
  • [Cites] Ann Surg. 1975 Nov;182(5):597-602 [1190864.001]
  • [Cites] Ann Surg. 1982 Sep;196(3):305-15 [7114936.001]
  • [Cites] Urology. 1984 Oct;24(4):312-4 [6485189.001]
  • [Cites] Cancer. 2006 Nov 15;107(10):2455-61 [17036354.001]
  • [Cites] Can J Surg. 1990 Aug;33(4):309-12 [2383839.001]
  • [Cites] Br J Surg. 1994 Dec;81(12):1771-4 [7827936.001]
  • [Cites] J Am Coll Surg. 1997 Sep;185(3):260-7 [9291404.001]
  • [Cites] J Surg Oncol. 1999 May;71(1):50-3 [10362092.001]
  • [Cites] AMA Arch Surg. 1955 Aug;71(2):254-6 [14397967.001]
  • [Cites] Ann Surg Oncol. 2006 Sep;13(9):1209-15 [16952046.001]
  • [Cites] Surg Gynecol Obstet. 1986 Dec;163(6):518-22 [3787425.001]
  • (PMID = 20501018.001).
  • [ISSN] 1478-7083
  • [Journal-full-title] Annals of the Royal College of Surgeons of England
  • [ISO-abbreviation] Ann R Coll Surg Engl
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC3025195
  •  go-up   go-down


59. Potocki K, Prutki M, Kralik M, Hrabak M, Padovan RS: Ewing's sarcoma of the third metatarsal: a case report and review of the literature. Tumori; 2007 Mar-Apr;93(2):210-2
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Ewing's sarcoma of the third metatarsal: a case report and review of the literature.
  • We report a rare case of Ewing's sarcoma involving the third metatarsal bone and spreading into adjacent bone in a 23-year-old man, with special emphasis on imaging characteristics.
  • Computed tomography and magnetic resonance imaging delineated the osseous and soft tissue extent of the tumor.
  • A large soft-tissue mass around the involved bone was highly indicative of Ewing's sarcoma.
  • An early diagnosis of Ewing's sarcoma, even when it occurs in unusual locations, is necessary for adequate treatment and is of particular importance in terms of prognosis.
  • The optimal imaging modality for the diagnosis of Ewing's sarcoma is magnetic resonance imaging since it allows accurate analysis of the soft-tissue component and visualization of possible local invasion of adjacent structures.
  • [MeSH-major] Diagnostic Imaging / methods. Metatarsal Bones / pathology. Sarcoma, Ewing / pathology
  • [MeSH-minor] Adult. Humans. Magnetic Resonance Imaging. Male. Neoplasm Invasiveness. Radiography. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Ewing's Sarcoma.
  • MedlinePlus Health Information. consumer health - Diagnostic Imaging.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17557573.001).
  • [ISSN] 0300-8916
  • [Journal-full-title] Tumori
  • [ISO-abbreviation] Tumori
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


60. Stepanova EV, Bokhian BIu, Petrovichev NN, Lichinitzer MR: [Thymidylate synthase, thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in soft-tissue sarcoma versus capecitabine potential]. Vopr Onkol; 2005;51(3):314-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Thymidylate synthase, thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in soft-tissue sarcoma versus capecitabine potential].
  • High TP expression was observed in 35 (42%) patients with soft-tissue sarcoma.
  • [MeSH-major] Antimetabolites, Antineoplastic / therapeutic use. Biomarkers, Tumor / analysis. Deoxycytidine / analogs & derivatives. Dihydrouracil Dehydrogenase (NADP) / analysis. Sarcoma / drug therapy. Thymidine Phosphorylase / analysis. Thymidylate Synthase / analysis
  • [MeSH-minor] Adult. Capecitabine. Female. Fluorouracil / analogs & derivatives. Gene Expression Regulation, Enzymologic. Gene Expression Regulation, Neoplastic. Humans. Male. Middle Aged. Predictive Value of Tests. Prognosis. Treatment Outcome

  • Genetic Alliance. consumer health - Soft tissue sarcoma.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • Hazardous Substances Data Bank. CAPECITABINE .
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16279094.001).
  • [ISSN] 0507-3758
  • [Journal-full-title] Voprosy onkologii
  • [ISO-abbreviation] Vopr Onkol
  • [Language] rus
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Russia (Federation)
  • [Chemical-registry-number] 0 / Antimetabolites, Antineoplastic; 0 / Biomarkers, Tumor; 0W860991D6 / Deoxycytidine; 6804DJ8Z9U / Capecitabine; EC 1.3.1.2 / Dihydrouracil Dehydrogenase (NADP); EC 2.1.1.45 / Thymidylate Synthase; EC 2.4.2.4 / Thymidine Phosphorylase; U3P01618RT / Fluorouracil
  •  go-up   go-down


61. Anderson ME, Hornicek FJ, Gebhardt MC, Raskin KA, Mankin HJ: Alveolar soft part sarcoma: a rare and enigmatic entity. Clin Orthop Relat Res; 2005 Sep;438:144-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Alveolar soft part sarcoma: a rare and enigmatic entity.
  • Alveolar soft part sarcoma is a rare malignant tumor with unusual clinical behavior.
  • Treatment of alveolar soft part sarcoma has been difficult to evaluate because of the small numbers of cases seen, but it seemed that although treatment of the primary tumor in alveolar soft part sarcoma often is successful, treatment of metastatic tumors is unsuccessful.
  • A review of outcome after treatment of primary and metastatic disease in the 15 patients in our database with alveolar soft part sarcoma was done in order to evaluate this issue.
  • New approaches to treatment of metastatic alveolar soft part sarcoma must be investigated and applied.
  • [MeSH-major] Neoplasm Metastasis / pathology. Sarcoma, Alveolar Soft Part / secondary. Soft Tissue Neoplasms / pathology
  • [MeSH-minor] Adolescent. Adult. Antineoplastic Combined Chemotherapy Protocols / administration & dosage. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Chemotherapy, Adjuvant. Cyclophosphamide / administration & dosage. Dacarbazine / administration & dosage. Doxorubicin / administration & dosage. Female. Humans. Ifosfamide / administration & dosage. Male. Mesna / administration & dosage. Neoplasm Staging. Survival Rate

  • Genetic Alliance. consumer health - Alveolar Soft Part Sarcoma.
  • COS Scholar Universe. author profiles.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • Hazardous Substances Data Bank. DOXORUBICIN .
  • Hazardous Substances Data Bank. IFOSFAMIDE .
  • Hazardous Substances Data Bank. DACARBAZINE .
  • Hazardous Substances Data Bank. CYCLOPHOSPHAMIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16131883.001).
  • [ISSN] 0009-921X
  • [Journal-full-title] Clinical orthopaedics and related research
  • [ISO-abbreviation] Clin. Orthop. Relat. Res.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 7GR28W0FJI / Dacarbazine; 80168379AG / Doxorubicin; 8N3DW7272P / Cyclophosphamide; NR7O1405Q9 / Mesna; UM20QQM95Y / Ifosfamide; MAID protocol
  •  go-up   go-down


62. Lin PP, Pino ED, Normand AN, Deavers MT, Cannon CP, Ballo MT, Pisters PW, Pollock RE, Lewis VO, Zagars GK, Yasko AW: Periosteal margin in soft-tissue sarcoma. Cancer; 2007 Feb 1;109(3):598-602
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Periosteal margin in soft-tissue sarcoma.
  • BACKGROUND: Soft-tissue sarcomas frequently rest in contact with bone.
  • METHODS: Fifty patients with soft-tissue sarcomas abutting bone were treated at a single institution between 1990 and 2004.
  • In 11 cases a composite resection of bone and soft tissue was performed.
  • In 39 cases the excision involved only soft tissue.
  • Local recurrence in the soft tissues developed in 8 of 50 (16%) patients.
  • There was no statistically significant difference in local recurrence between patients who had composite bone resection and patients who had soft-tissue resection only (P = .87).
  • Composite bone and soft-tissue resections are indicated primarily for frank bone invasion.
  • [MeSH-major] Bone Neoplasms / pathology. Neoplasm Recurrence, Local / pathology. Periosteum / pathology. Sarcoma / pathology. Soft Tissue Neoplasms / pathology
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Female. Humans. Male. Middle Aged. Retrospective Studies. Survival Rate


63. Francis P, Fernebro J, Edén P, Laurell A, Rydholm A, Domanski HA, Breslin T, Hegardt C, Borg A, Nilbert M: Intratumor versus intertumor heterogeneity in gene expression profiles of soft-tissue sarcomas. Genes Chromosomes Cancer; 2005 Jul;43(3):302-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intratumor versus intertumor heterogeneity in gene expression profiles of soft-tissue sarcomas.
  • Soft-tissue sarcomas (STSs) constitute more than 30 histologic entities.
  • We concluded that intratumor variability exists but that accurate gene expression profiling also could be obtained using single samples from a large STS.
  • [MeSH-major] Gene Expression Profiling. Sarcoma / genetics
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Female. Humans. Male. Middle Aged. Necrosis. Neoplasm Invasiveness. Oligonucleotide Array Sequence Analysis

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2005 Wiley-Liss, Inc.
  • (PMID = 15834945.001).
  • [ISSN] 1045-2257
  • [Journal-full-title] Genes, chromosomes & cancer
  • [ISO-abbreviation] Genes Chromosomes Cancer
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


64. Sung KS, Seo SW, Shon MS: The diagnostic value of needle biopsy for musculoskeletal lesions. Int Orthop; 2009 Dec;33(6):1701-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • There were 142 soft tissue and 167 bony lesions.
  • Overall diagnostic yield was 90.6% for all 309 lesions (bone 91.6% vs. soft tissue 89.3%, p = 0.5125).
  • The diagnostic accuracy of the 185 core needle biopsies, which were confirmed by definitive surgical biopsies, was 84.3% (bone 88.9% vs. soft tissue 79.1%, p = 0.0669).
  • However, for soft tissue tumours, homogenous tumours had a significantly higher diagnostic yield than heterogenous tumours (97.5% vs. 81.4%, p = 0.0036).
  • Diagnostic accuracy for homogenous tumours was also significantly higher than that for heterogenous soft tissue tumours (94.4% vs. 60.6%, p < 0.0001).
  • The image-guided percutaneous needle biopsy of musculoskeletal lesions is a safe and effective procedure if it is performed selectively in soft tissue tumours with homogenous architectures.
  • [MeSH-major] Biopsy, Needle / methods. Bone Neoplasms / diagnosis. Musculoskeletal Diseases / diagnosis. Soft Tissue Neoplasms / diagnosis
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Child. Child, Preschool. Diagnosis, Computer-Assisted. Diagnosis, Differential. Female. Hemangioma / diagnosis. Hemangioma / pathology. Humans. Image Processing, Computer-Assisted. Male. Middle Aged. Neurilemmoma / diagnosis. Neurilemmoma / pathology. Retrospective Studies. Sarcoma, Synovial / diagnosis. Sarcoma, Synovial / pathology. Young Adult

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Bone Joint Surg Br. 2000 Jan;82(1):50-4 [10697314.001]
  • [Cites] Radiology. 2008 Sep;248(3):962-70 [18710986.001]
  • [Cites] Cancer. 2000 Dec 15;89(12):2677-86 [11135231.001]
  • [Cites] J Ultrasound Med. 2000 Dec;19(12):849-55 [11127010.001]
  • [Cites] Am J Clin Pathol. 2001 Jan;115(1):59-68 [11190808.001]
  • [Cites] J Ultrasound Med. 2002 Mar;21(3):275-81 [11883538.001]
  • [Cites] Radiology. 2002 Jun;223(3):731-7 [12034942.001]
  • [Cites] Isr Med Assoc J. 2003 Jan;5(1):28-30 [12592954.001]
  • [Cites] J Radiol. 2003 Jun;84(6):693-7 [12910175.001]
  • [Cites] Radiology. 1983 Dec;149(3):675-9 [6580673.001]
  • [Cites] Acta Cytol. 1987 Mar-Apr;31(2):177-84 [3469851.001]
  • [Cites] AJR Am J Roentgenol. 1992 Apr;158(4):809-12 [1546597.001]
  • [Cites] J Bone Joint Surg Br. 1991 May;73(3):498-500 [1670457.001]
  • [Cites] AJR Am J Roentgenol. 1996 Jan;166(1):137-41 [8571862.001]
  • [Cites] J Bone Joint Surg Am. 1996 May;78(5):644-9 [8642019.001]
  • [Cites] J Bone Joint Surg Am. 1996 May;78(5):656-63 [8642021.001]
  • [Cites] AJR Am J Roentgenol. 1998 Sep;171(3):759-62 [9725312.001]
  • [Cites] Can Assoc Radiol J. 1999 Apr;50(2):121-5 [10226638.001]
  • [Cites] Am J Clin Pathol. 1999 May;111(5):594-8 [10230349.001]
  • [Cites] Radiology. 1999 Sep;212(3):682-6 [10478232.001]
  • [Cites] ANZ J Surg. 2005 Apr;75(4):187-91 [15839962.001]
  • [Cites] J Surg Oncol. 2006 Jul 1;94(1):21-7 [16788939.001]
  • [Cites] Int Orthop. 2006 Dec;30(6):484-9 [17013643.001]
  • [Cites] Rev Med Chil. 2006 Oct;134(10):1283-7 [17186098.001]
  • [Cites] Skeletal Radiol. 2007 Mar;36(3):181-2 [17139502.001]
  • [Cites] J Ultrasound Med. 2000 Jul;19(7):465-71 [10898300.001]
  • (PMID = 19655141.001).
  • [ISSN] 1432-5195
  • [Journal-full-title] International orthopaedics
  • [ISO-abbreviation] Int Orthop
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] Germany
  • [Other-IDs] NLM/ PMC2899198
  •  go-up   go-down


65. Périgny M, Dion N, Couture C, Lagacé R: [Low grade fibromyxoid sarcoma: a clinico-pathologic analysis of 7 cases]. Ann Pathol; 2006 Dec;26(6):419-25
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Low grade fibromyxoid sarcoma: a clinico-pathologic analysis of 7 cases].
  • OBJECTIVES: Low-grade fibromyxoid sarcoma (LGFMS) is a malignant soft tissue tumor.
  • One of them demonstrated an area of dedifferentiation into a high grade pleomorphic sarcoma, malignant fibrous histiocytoma (MFH) type.
  • We report a unique case with areas of high grade sarcoma, MFH type, and areas similar to sclerosing epithelioid fibrosarcoma.
  • [MeSH-major] Fibroma / pathology. Sarcoma / pathology
  • [MeSH-minor] Adolescent. Adult. Female. Humans. Male. Middle Aged. Neoplasm Staging

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17255901.001).
  • [ISSN] 0242-6498
  • [Journal-full-title] Annales de pathologie
  • [ISO-abbreviation] Ann Pathol
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


66. Rehders A, Peiper M, Stoecklein NH, Alexander A, Boelke E, Knoefel WT, Rogiers X: Hepatic metastasectomy for soft-tissue sarcomas: is it justified? World J Surg; 2009 Jan;33(1):111-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Hepatic metastasectomy for soft-tissue sarcomas: is it justified?
  • BACKGROUND: Except for patients with gastrointestinal stromal tumors (GIST), systemic chemotherapy in patients with liver metastasis of soft-tissue sarcoma (STS) is not effective.
  • METHODS: All patients (n=45) with liver metastasis of STS undergoing surgical therapy were prospectively analyzed.
  • [MeSH-major] Liver Neoplasms / surgery. Neoplasm Recurrence, Local / surgery. Sarcoma / surgery. Soft Tissue Neoplasms / pathology
  • [MeSH-minor] Adult. Aged. Female. Humans. Kaplan-Meier Estimate. Longitudinal Studies. Male. Middle Aged. Neoplasm Staging. Reoperation. Survival Rate. Time Factors. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Surg Oncol. 2004 Sep 1;87(3):116-20 [15334637.001]
  • [Cites] J Clin Oncol. 2003 Jul 15;21(14):2719-25 [12860950.001]
  • [Cites] Ann Surg. 2005 Aug;242(2):158-71 [16041205.001]
  • [Cites] Am J Clin Oncol. 1999 Feb;22(1):70-2 [10025385.001]
  • [Cites] Ann Surg. 2000 Apr;231(4):500-5 [10749609.001]
  • [Cites] Surg Endosc. 2005 Dec;19(12):1613-7 [16247574.001]
  • [Cites] Jpn J Clin Oncol. 2005 Jun;35(6):338-41 [15928191.001]
  • [Cites] J Clin Oncol. 1996 May;14(5):1679-89 [8622088.001]
  • [Cites] Cancer. 2001 May 15;91(10):1914-26 [11346874.001]
  • [Cites] Acta Orthop Scand Suppl. 1999 Jun;285:50-7 [10429623.001]
  • [Cites] Hepatology. 1996 Dec;24(6):1386-91 [8938166.001]
  • [Cites] Cancer. 2004 May 15;100(10):2233-9 [15139069.001]
  • [Cites] J Clin Oncol. 2000 Jul;18(14):2676-84 [10894866.001]
  • [Cites] Cochrane Database Syst Rev. 2003;(3):CD003293 [12917960.001]
  • [Cites] Cancer. 2000 Jan 1;88(1):66-74 [10618607.001]
  • [Cites] Br J Cancer. 2006 Apr 10;94(7):982-99 [16538219.001]
  • [Cites] Ann Surg. 1995 Apr;221(4):392-7 [7726675.001]
  • [Cites] Ann Surg. 2001 Oct;234(4):540-7; discussion 547-8 [11573047.001]
  • [Cites] J Hepatobiliary Pancreat Surg. 2003;10(1):77-80 [12827476.001]
  • [Cites] Hepatology. 1995 May;21(5):1317-21 [7737637.001]
  • [Cites] Cancer. 1999 Jan 15;85(2):389-95 [10023707.001]
  • [Cites] J Clin Oncol. 2002 Nov 1;20(21):4344-52 [12409334.001]
  • (PMID = 18949511.001).
  • [ISSN] 0364-2313
  • [Journal-full-title] World journal of surgery
  • [ISO-abbreviation] World J Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


67. Gortzak Y, Lockwood GA, Mahendra A, Wang Y, Chung PW, Catton CN, O'Sullivan B, Deheshi BM, Wunder JS, Ferguson PC: Prediction of pathologic fracture risk of the femur after combined modality treatment of soft tissue sarcoma of the thigh. Cancer; 2010 Mar 15;116(6):1553-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Prediction of pathologic fracture risk of the femur after combined modality treatment of soft tissue sarcoma of the thigh.
  • BACKGROUND: The objective of the current study was to formulate a scoring system to enable decision making for prophylactic stabilization of the femur after surgical resection of a soft tissue sarcoma (STS) of the thigh.
  • The study group included 22 patients who developed a radiation-related pathological fracture of the femur after surgery and radiotherapy for an STS of the thigh.
  • CONCLUSIONS: Radiation-related fractures of the femur after combined surgery and radiotherapy for STS are uncommon, but are difficult to manage and their nonunion rate is extremely high.
  • [MeSH-major] Combined Modality Therapy / adverse effects. Femur. Fractures, Spontaneous / complications. Sarcoma / complications. Thigh
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Female. Humans. Logistic Models. Male. Middle Aged. Nomograms. Prognosis. Radiotherapy Dosage. Risk Assessment. Sensitivity and Specificity

  • Genetic Alliance. consumer health - Soft tissue sarcoma.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20108335.001).
  • [ISSN] 0008-543X
  • [Journal-full-title] Cancer
  • [ISO-abbreviation] Cancer
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


68. Sakuraba M, Kimata Y, Iida H, Beppu Y, Chuman H, Kawai A: Pelvic ring reconstruction with the double-barreled vascularized fibular free flap. Plast Reconstr Surg; 2005 Oct;116(5):1340-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: In one patient, a pedicled rectus abdominis musculocutaneous flap was transferred to repair defects of the skin and underlying soft tissue.
  • [MeSH-minor] Adolescent. Adult. Chondrosarcoma / radiography. Chondrosarcoma / surgery. Female. Humans. Ilium. Male. Middle Aged. Osteosarcoma / surgery. Reconstructive Surgical Procedures / methods. Sarcoma, Ewing / surgery. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • MedlinePlus Health Information. consumer health - Bone Grafts.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16217477.001).
  • [ISSN] 1529-4242
  • [Journal-full-title] Plastic and reconstructive surgery
  • [ISO-abbreviation] Plast. Reconstr. Surg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


69. Park JH, Kang CH, Kim CH, Chae IJ, Park JH: Highly malignant soft tissue sarcoma of the extremity with a delayed diagnosis. World J Surg Oncol; 2010;8:84
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Highly malignant soft tissue sarcoma of the extremity with a delayed diagnosis.
  • PURPOSE: To evaluate the characteristics of highly malignant soft tissue sarcoma of the extremity with a delayed diagnosis.
  • MATERIALS AND METHODS: The clinical and radiological characteristics of 18 cases of highly malignant soft tissue sarcomas of the extremity with a delayed diagnosis were determined.
  • Seven cases of synovial sarcoma, three cases each of alveolar soft part sarcoma and malignant fibrous histiocytoma, two cases each of highly malignant leiomyosarcoma and myxofibrosarcoma, and one case of clear cell sarcoma were enrolled.
  • Times from tumor detection to diagnosis ranged from 1 to 3 years in most cases; three of the seven synovial sarcoma cases took more than 10 years to diagnose.
  • Of the seven cases of synovial sarcoma, five cases of small, superficial located masses were simply excised without a pre-surgical biopsy.
  • Three cases of alveolar soft part sarcoma showed characteristic T1- and T2-weighted high signal intensities with signal voids in MR images.
  • In addition, one synovial sarcoma patient and one alveolar soft part sarcoma patient showed evidence of calcification on plain radiographs.
  • CONCLUSIONS: Contrary to general expectations, some soft tissue tumors that grow slowly are painless, and those that occur in superficial limbs may be highly malignant.
  • Thus, even when a slow growing, painless superficial mass is encountered in a limb, physicians should keep the possibility of highly malignant soft tissue sarcoma in mind.
  • [MeSH-major] Delayed Diagnosis. Forearm. Leg. Magnetic Resonance Imaging / methods. Neoplasm Staging / methods. Sarcoma / diagnosis
  • [MeSH-minor] Adolescent. Adult. Aged. Diagnosis, Differential. Female. Follow-Up Studies. Humans. Male. Middle Aged. Prognosis. Retrospective Studies. Time Factors. Young Adult

  • Genetic Alliance. consumer health - Soft tissue sarcoma.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Skeletal Radiol. 2000 Dec;29(12):680-9 [11271548.001]
  • [Cites] Ann Surg Oncol. 1999 Jan-Feb;6(1):8-9 [10030406.001]
  • [Cites] J Bone Joint Surg Am. 1976 Apr;58(3):317-27 [177425.001]
  • [Cites] J Bone Joint Surg Am. 1982 Jan;64(1):112-22 [6274877.001]
  • [Cites] Cancer. 1982 Jul 15;50(2):345-52 [6282441.001]
  • [Cites] Ann Surg. 1987 Apr;205(4):349-59 [3566372.001]
  • [Cites] J Vasc Surg. 1987 Oct;6(4):419-21 [3656589.001]
  • [Cites] Cancer. 1989 Jan 1;63(1):1-13 [2642727.001]
  • [Cites] AJR Am J Roentgenol. 1989 Aug;153(2):335-9 [2750619.001]
  • [Cites] Orthop Rev. 1992 Apr;21(4):465-71 [1315945.001]
  • [Cites] AJR Am J Roentgenol. 1995 Jan;164(1):129-34 [7998525.001]
  • [Cites] Skeletal Radiol. 1995 May;24(4):267-70 [7644939.001]
  • [Cites] J Bone Joint Surg Am. 1996 May;78(5):650-5 [8642020.001]
  • [Cites] Clin Radiol. 1997 Aug;52(8):595-602 [9285419.001]
  • [Cites] Pediatr Radiol. 2001 Mar;31(3):196-9 [11297086.001]
  • (PMID = 20863406.001).
  • [ISSN] 1477-7819
  • [Journal-full-title] World journal of surgical oncology
  • [ISO-abbreviation] World J Surg Oncol
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2955565
  •  go-up   go-down


70. Ramseier LE, Dumont CE, Bode-Lesniewska B, Lombriser N, Exner GU: Results of treatment of malignant soft tissue tumours in the groin. Scand J Plast Reconstr Surg Hand Surg; 2008;42(5):241-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Results of treatment of malignant soft tissue tumours in the groin.
  • Soft tissue sarcomas of the inguinal region are a challenge with regard to achieving clear margins, reconstruction of the femoral vessels, and soft tissue coverage.
  • Six men aged 39 to 48 years and one woman of 56 were treated for soft tissue sarcomas of the groin.
  • In two patients the soft tissue defect was covered primarily with an ipsilateral rectus abdominis muscle flap, in two others (because of wound dehiscence) coverage was achieved with the opposite rectus abdominis muscle pedicle flap as we were afraid of closure of the ipsilateral deep epigastric vessels.
  • A high rate of local tumour control in soft tissue sarcomas of the inguinal region can be achieved with the combination of surgical resection and radiotherapy.
  • No compromise should be made with aggressive soft tissue coverage to protect the vascular reconstruction, control wound healing after neoadjuvant radiotherapy, or allow immediate adjuvant radiotherapy.

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18821449.001).
  • [ISSN] 0284-4311
  • [Journal-full-title] Scandinavian journal of plastic and reconstructive surgery and hand surgery
  • [ISO-abbreviation] Scand J Plast Reconstr Surg Hand Surg
  • [Language] ENG
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


71. Shah AK, Grant I: Intravascular papillary endothelial hyperplasia (Masson's tumour) causing a soft-tissue mass in the upper limb. Hand Surg; 2010;15(1):31-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intravascular papillary endothelial hyperplasia (Masson's tumour) causing a soft-tissue mass in the upper limb.
  • Masson's tumour (intravascular papillary endothelial hyperplasia) is a benign vascular tumour, which can present in a similar manner to a soft-tissue sarcoma.
  • [MeSH-major] Elbow. Endothelium, Vascular / pathology. Neoplasms, Vascular Tissue / surgery
  • [MeSH-minor] Adult. Female. Hemangioendothelioma / diagnosis. Humans. Magnetic Resonance Imaging. Sarcoma / diagnosis

  • Genetic Alliance. consumer health - Intravascular papillary endothelial hyperplasia.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20422724.001).
  • [ISSN] 1793-6535
  • [Journal-full-title] Hand surgery : an international journal devoted to hand and upper limb surgery and related research : journal of the Asia-Pacific Federation of Societies for Surgery of the Hand
  • [ISO-abbreviation] Hand Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Singapore
  •  go-up   go-down


72. Kaste SC, Ahn H, Liu T, Liu W, Krasin MJ, Hudson MM, Spunt SL: Bone mineral density deficits in pediatric patients treated for sarcoma. Pediatr Blood Cancer; 2008 May;50(5):1032-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Bone mineral density deficits in pediatric patients treated for sarcoma.
  • BACKGROUND: Children treated for sarcoma are at risk of treatment-associated deficits in bone mineral density (BMD).
  • PROCEDURE: Using signed-rank test and logistic regression analysis, we retrospectively analyzed the relation of treatment variables and other potential risk factors to BMD (using quantitative computed tomography (QCT)) of 99 patients treated for pediatric sarcoma who had completed therapy at least 1 year previously.
  • RESULTS: The study group (38% rhabdomyosarcoma (RMS), 25% osteosarcoma (OS), 24% Ewing-family tumors, and 12% non-rhabdomyosarcoma soft-tissue sarcoma (NRSTS)) represented 22% of the sarcoma survivors treated between 1982 and 2003 who remained in follow-up at St. Jude.
  • CONCLUSION: A significant subset of sarcoma survivors are at risk of BMD deficits warranting prospective study of BMD to verify our results and refine risk factors contributing to BMD deficits.

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • MedlinePlus Health Information. consumer health - Bone Density.
  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2008 Wiley-Liss, Inc.
  • (PMID = 17570705.001).
  • [ISSN] 1545-5017
  • [Journal-full-title] Pediatric blood & cancer
  • [ISO-abbreviation] Pediatr Blood Cancer
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / P01 CA020180; United States / NCI NIH HHS / CA / P01 CA-20180; United States / NCI NIH HHS / CA / P30 CA-21765
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


73. Gupta A, Rao HK, Gupta S: The incidence of soft tissue sarcoma in Dakshina Kannada: study in a District Government Hospital. Indian J Surg; 2009 Feb;71(1):10-4
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The incidence of soft tissue sarcoma in Dakshina Kannada: study in a District Government Hospital.
  • BACKGROUND: We present a retrospective study depicting the incidence and outcome of soft tissue sarcomas (STSs) in patients admitted in a District Government Hospital situated in coastal belt of Southern India for a period of four and a half years.
  • METHODS: Histologically proven soft tissue STS patients admitted in Department of General Surgery in District Government Wenlock Hospital, Mangalore, from January 2002 to July 2007 were included in the study.
  • RESULTS: Fifty-one cases of STS were reported out of 7674 (0.65%) patients with cancer in the said period.
  • Ninety percent belonged to adolescents and adult age group.
  • Liposarcoma (18%) is the most common subtype followed by leiomyosarcoma, Ewings' sarcoma.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Oncol. 1992 Aug;10(8):1317-29 [1634922.001]
  • [Cites] Am J Pathol. 1994 Jun;144(6):1121-34 [8203453.001]
  • [Cites] Can J Surg. 1993 Apr;36(2):178-80 [8472231.001]
  • [Cites] Cancer Treat Res. 1997;91:9-29 [9286486.001]
  • [Cites] Virchows Arch. 2001 Aug;439(2):141-51 [11561754.001]
  • [Cites] Ann Surg Oncol. 1999 Jan-Feb;6(1):8-9 [10030406.001]
  • [Cites] Verh Dtsch Ges Pathol. 1997;81:318-26 [9474886.001]
  • (PMID = 23133101.001).
  • [ISSN] 0972-2068
  • [Journal-full-title] The Indian journal of surgery
  • [ISO-abbreviation] Indian J Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC3452575
  • [Keywords] NOTNLM ; Dakshina Kannada / District Government Wenlock Hospital / Incidence / Soft tissue sarcoma
  •  go-up   go-down


74. Moustafellos P, Gourgiotis S, Athanasopoulos G, Karagianni E, Hadjiyannakis E: A spontaneously ruptured primitive neuroectodermal tumor/extraosseous Ewing's sarcoma of the kidney with renal vein tumor thrombus. Int Urol Nephrol; 2007;39(2):393-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A spontaneously ruptured primitive neuroectodermal tumor/extraosseous Ewing's sarcoma of the kidney with renal vein tumor thrombus.
  • Primitive neuroectodermal tumor/extraosseous Ewing's sarcoma (PNET/EES) is a childhood disease rarely seen in adults.
  • It is a soft tissue tumor, which is often observed in the paraspinal region and lower extremity.
  • [MeSH-major] Kidney Neoplasms / complications. Neoplastic Cells, Circulating. Neuroectodermal Tumors, Primitive / complications. Renal Veins. Sarcoma, Ewing / complications
  • [MeSH-minor] Adult. Humans. Male. Rupture, Spontaneous

  • Genetic Alliance. consumer health - Ewing's Sarcoma.
  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Surg Pathol. 1997 Mar;21(3):354-9 [9060607.001]
  • [Cites] J Clin Oncol. 1997 Jul;15(7):2611-21 [9215832.001]
  • [Cites] J Urol. 2000 Sep;164(3 Pt 1):772 [10953145.001]
  • [Cites] J Clin Oncol. 1997 Feb;15(2):574-82 [9053479.001]
  • [Cites] Am J Surg Pathol. 1997 Apr;21(4):461-8 [9130994.001]
  • [Cites] Cancer. 1997 Jun 1;79(11):2243-50 [9179073.001]
  • [Cites] Urol Int. 2002;69(2):150-2 [12187048.001]
  • (PMID = 17310314.001).
  • [ISSN] 0301-1623
  • [Journal-full-title] International urology and nephrology
  • [ISO-abbreviation] Int Urol Nephrol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


75. Jakob J, Wenz F, Dinter DJ, Ströbel P, Hohenberger P: Preoperative intensity-modulated radiotherapy combined with temozolomide for locally advanced soft-tissue sarcoma. Int J Radiat Oncol Biol Phys; 2009 Nov 1;75(3):810-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Preoperative intensity-modulated radiotherapy combined with temozolomide for locally advanced soft-tissue sarcoma.
  • PURPOSE: To evaluate the toxicity and efficacy of preoperative intensity-modulated radiotherapy (IMRT) combined with temozolomide to improve local tumor control in soft-tissue sarcoma (STS).
  • PATIENTS AND METHODS: A cohort of 15 consecutive patients with nonmetastasized, primary high-grade or locally recurrent Stage III (n = 14) or IIb (n = 1) STS not amenable to surgical resection without significant organ or extremity function loss was prospectively investigated.
  • CONCLUSIONS: Preoperative chemoradiation with temozolomide and IMRT can be administered safely and with promising efficacy in patients with locally advanced STS.
  • [MeSH-major] Antineoplastic Agents, Alkylating / therapeutic use. Dacarbazine / analogs & derivatives. Radiotherapy, Intensity-Modulated. Sarcoma
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Combined Modality Therapy / adverse effects. Combined Modality Therapy / methods. Female. Humans. Male. Middle Aged. Nausea / etiology. Postoperative Complications. Prospective Studies. Radiation Injuries / etiology. Radiotherapy Dosage. Remission Induction. Tumor Burden. Vomiting / etiology

  • Genetic Alliance. consumer health - Soft tissue sarcoma.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • Hazardous Substances Data Bank. DACARBAZINE .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19307066.001).
  • [ISSN] 1879-355X
  • [Journal-full-title] International journal of radiation oncology, biology, physics
  • [ISO-abbreviation] Int. J. Radiat. Oncol. Biol. Phys.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Alkylating; 7GR28W0FJI / Dacarbazine; 85622-93-1 / temozolomide
  •  go-up   go-down


76. Cil T, Altintas A, Isikdogan A: Rhabdomyosarcoma presenting with destructive large lesion of the face. South Med J; 2008 Jan;101(1):104-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children and adolescents.
  • Prognostic factors of RMS include tumor status, primary tumor site, localization in the organ or tissue of origin, patient age and histopathological type.
  • [MeSH-major] Facial Neoplasms / diagnosis. Rhabdomyosarcoma, Alveolar / diagnosis. Sarcoma / diagnosis
  • [MeSH-minor] Adult. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Combined Modality Therapy. Female. Humans. Immunohistochemistry

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18176304.001).
  • [ISSN] 1541-8243
  • [Journal-full-title] Southern medical journal
  • [ISO-abbreviation] South. Med. J.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


77. Nathan PC, Tsokos M, Long L, Bernstein D, Wexler LH, Mackall CL, Helman LJ: Adjuvant chemotherapy for the treatment of advanced pediatric nonrhabdomyosarcoma soft tissue sarcoma: the National Cancer Institute experience. Pediatr Blood Cancer; 2005 May;44(5):449-54
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adjuvant chemotherapy for the treatment of advanced pediatric nonrhabdomyosarcoma soft tissue sarcoma: the National Cancer Institute experience.
  • BACKGROUND: The survival of children and adolescents with advanced (unresectable or metastatic) nonrhabdomyosarcoma soft tissue sarcoma (NRSTS) is poor.
  • [MeSH-major] Soft Tissue Neoplasms / drug therapy
  • [MeSH-minor] Adolescent. Adult. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Chemotherapy, Adjuvant. Child. Child, Preschool. Combined Modality Therapy. Doxorubicin / therapeutic use. Female. Humans. Infant. Male. Neoplasm Metastasis. Remission Induction / methods. Retrospective Studies. Survival Analysis

  • Genetic Alliance. consumer health - Soft tissue sarcoma.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. DOXORUBICIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Published 2004 Wiley-Liss, Inc.
  • [CommentIn] Pediatr Blood Cancer. 2005 Aug;45(2):226-7; author reply 228 [15782404.001]
  • (PMID = 15547929.001).
  • [ISSN] 1545-5009
  • [Journal-full-title] Pediatric blood & cancer
  • [ISO-abbreviation] Pediatr Blood Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 80168379AG / Doxorubicin
  •  go-up   go-down


78. Pfannschmidt J, Klode J, Muley T, Dienemann H, Hoffmann H: Pulmonary metastasectomy in patients with soft tissue sarcomas: experiences in 50 patients. Thorac Cardiovasc Surg; 2006 Oct;54(7):489-92
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pulmonary metastasectomy in patients with soft tissue sarcomas: experiences in 50 patients.
  • BACKGROUND: Pulmonary resection of metastatic soft tissue sarcomas is an accepted method of treatment.
  • METHODS: Between 1996 and 2001, 50 patients (27 men, 23 women) with pulmonary metastases from a soft tissue sarcoma underwent surgical resection.
  • CONCLUSION: We conclude that pulmonary resection of metastatic soft tissue sarcomas is a safe and effective treatment, which offers an improved survival benefit.
  • [MeSH-major] Lung Neoplasms / surgery. Sarcoma / surgery
  • [MeSH-minor] Adolescent. Adult. Aged. Female. Humans. Male. Middle Aged. Prognosis. Retrospective Studies. Survival Analysis

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17089318.001).
  • [ISSN] 0171-6425
  • [Journal-full-title] The Thoracic and cardiovascular surgeon
  • [ISO-abbreviation] Thorac Cardiovasc Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


79. Jebsen NL, Trovik CS, Bauer HC, Rydholm A, Monge OR, Hall KS, Alvegård T, Bruland OS: Radiotherapy to improve local control regardless of surgical margin and malignancy grade in extremity and trunk wall soft tissue sarcoma: a Scandinavian sarcoma group study. Int J Radiat Oncol Biol Phys; 2008 Jul 15;71(4):1196-203
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Radiotherapy to improve local control regardless of surgical margin and malignancy grade in extremity and trunk wall soft tissue sarcoma: a Scandinavian sarcoma group study.
  • PURPOSE: Adjuvant radiotherapy has during the past decades become increasingly used in the treatment of localized soft tissue sarcoma.
  • METHODS AND MATERIALS: A total of 1,093 adult patients with extremity or trunk wall soft tissue sarcoma treated at four Scandinavian sarcoma centers were stratified according to the treatment period (1986-1991, 1992-1997, and 1998-2005).
  • CONCLUSION: The results of our study have shown that adjuvant RT effectively prevents local recurrence in soft tissue sarcoma, irrespective of the tumor depth, malignancy grade, and surgical margin status.
  • [MeSH-major] Neoplasm Recurrence, Local / epidemiology. Neoplasm Recurrence, Local / prevention & control. Sarcoma / radiotherapy. Sarcoma / surgery
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Extremities. Female. Humans. Incidence. Male. Middle Aged. Norway / epidemiology. Radiotherapy, Adjuvant / statistics & numerical data. Retrospective Studies. Sweden / epidemiology. Thorax. Treatment Outcome


80. Hegazy MA, Kotb SZ, Sakr H, El Dosoky E, Amer T, Hegazi RA, Farouk O: Preoperative isolated limb infusion of Doxorubicin and external irradiation for limb-threatening soft tissue sarcomas. Ann Surg Oncol; 2007 Feb;14(2):568-76
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Preoperative isolated limb infusion of Doxorubicin and external irradiation for limb-threatening soft tissue sarcomas.
  • BACKGROUND: At present, limb-sparing surgery is the most appropriate and acceptable treatment option for soft tissue sarcomas of the extremities.
  • To increase the number of limb-sparing resections in the treatment of locally advanced soft tissue sarcomas of the extremities, preoperative radiotherapy and/or chemotherapy are often used.
  • OBJECTIVE: The objective of this study was to achieve limb-sparing surgery in patients with locally advanced soft tissue sarcomas of the extremities that would otherwise have required an amputation or a functionally mutilating surgery by performing preoperative isolated limb infusion with doxorubicin and external beam irradiation to obtain local control and make limb-sparing surgery feasible.
  • METHODS: A total of 40 patients with locally advanced soft tissue sarcomas of the extremities were evaluated between 2002 and 2005.
  • The addition of preoperative external beam irradiation helped to increase the rate of limb salvage in patients with large and/or high-grade soft tissue sarcomas of the extremities.
  • [MeSH-major] Chemotherapy, Cancer, Regional Perfusion. Sarcoma / therapy. Soft Tissue Neoplasms / therapy
  • [MeSH-minor] Adult. Aged. Antibiotics, Antineoplastic / administration & dosage. Combined Modality Therapy. Doxorubicin / administration & dosage. Extremities. Feasibility Studies. Female. Humans. Limb Salvage / methods. Male. Middle Aged. Preoperative Care

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • Hazardous Substances Data Bank. DOXORUBICIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17094027.001).
  • [ISSN] 1068-9265
  • [Journal-full-title] Annals of surgical oncology
  • [ISO-abbreviation] Ann. Surg. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antibiotics, Antineoplastic; 80168379AG / Doxorubicin
  •  go-up   go-down


81. Otterson GA, Villalona-Calero MA, Sharma S, Kris MG, Imondi A, Gerber M, White DA, Ratain MJ, Schiller JH, Sandler A, Kraut M, Mani S, Murren JR: Phase I study of inhaled Doxorubicin for patients with metastatic tumors to the lungs. Clin Cancer Res; 2007 Feb 15;13(4):1246-52
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The most common histologic diagnoses were sarcoma (n = 19) and non-small cell lung cancer (n = 16).
  • Observed activity included a partial response in a patient with metastatic soft tissue sarcoma previously treated with i.v. doxorubicin and ifosfamide.
  • [MeSH-minor] Administration, Inhalation. Adult. Aerosols / administration & dosage. Aged. Dose-Response Relationship, Drug. Female. Humans. Male. Middle Aged. Neoplasm Metastasis

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. DOXORUBICIN .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17317836.001).
  • [ISSN] 1078-0432
  • [Journal-full-title] Clinical cancer research : an official journal of the American Association for Cancer Research
  • [ISO-abbreviation] Clin. Cancer Res.
  • [Language] eng
  • [Publication-type] Clinical Trial, Phase I; Journal Article; Multicenter Study
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Aerosols; 0 / Antibiotics, Antineoplastic; 80168379AG / Doxorubicin
  •  go-up   go-down


82. Daigeler A, Kuçi H, Altmann S, Schneider W, Röcken C: Extramedullary multiple myeloma associated with amyloidomas of the lower limbs. Plast Reconstr Surg; 2006 Jun;117(7):2530-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Amyloidosis / pathology. Multiple Myeloma / pathology. Multiple Myeloma / therapy. Soft Tissue Neoplasms / pathology. Soft Tissue Neoplasms / therapy
  • [MeSH-minor] Adult. Biopsy. Female. Humans. Lower Extremity

  • Genetic Alliance. consumer health - Multiple myeloma.
  • MedlinePlus Health Information. consumer health - Amyloidosis.
  • MedlinePlus Health Information. consumer health - Multiple Myeloma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16772994.001).
  • [ISSN] 1529-4242
  • [Journal-full-title] Plastic and reconstructive surgery
  • [ISO-abbreviation] Plast. Reconstr. Surg.
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] United States
  •  go-up   go-down


83. Kobayashi E, Kawai A, Endo M, Suehara Y, Takeda K, Nakatani F, Asano T, Sakuraba M, Chuman H, Seki K, Beppu Y: Myxoinflammatory fibroblastic sarcoma. J Orthop Sci; 2008 Nov;13(6):566-71
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Myxoinflammatory fibroblastic sarcoma.
  • [MeSH-major] Fibrosarcoma / pathology. Soft Tissue Neoplasms / pathology
  • [MeSH-minor] Adolescent. Adult. Aged, 80 and over. Female. Humans. Magnetic Resonance Imaging. Male. Middle Aged

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19089546.001).
  • [ISSN] 0949-2658
  • [Journal-full-title] Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association
  • [ISO-abbreviation] J Orthop Sci
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


84. Boniver V, Moreau P, Lefebvre P: Synovial sarcoma of the larynx: case report and literature review. B-ENT; 2005;1(1):47-51
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Synovial sarcoma of the larynx: case report and literature review.
  • Synovial sarcoma is a rare mesenchymal malignancy which represents 8.5% of all soft tissue sarcomas and usually occurs in the lower extremities of young adults.
  • We present here a case of aryepiglottic synovial sarcoma.
  • [MeSH-major] Laryngeal Neoplasms / epidemiology. Sarcoma, Synovial / epidemiology
  • [MeSH-minor] Adult. Endoscopy. Female. Humans. Laser Therapy

  • Genetic Alliance. consumer health - Synovial sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15999676.001).
  • [ISSN] 1781-782X
  • [Journal-full-title] B-ENT
  • [ISO-abbreviation] B-ENT
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Belgium
  • [Number-of-references] 19
  •  go-up   go-down


85. Izumi T, Oda Y, Hasegawa T, Nakanishi Y, Kawai A, Sonobe H, Takahira T, Kobayashi C, Yamamoto H, Tamiya S, Hirohashi S, Iwamoto Y, Tsuneyoshi M: Dysadherin expression as a significant prognostic factor and as a determinant of histologic features in synovial sarcoma: special reference to its inverse relationship with E-cadherin expression. Am J Surg Pathol; 2007 Jan;31(1):85-94
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Dysadherin expression as a significant prognostic factor and as a determinant of histologic features in synovial sarcoma: special reference to its inverse relationship with E-cadherin expression.
  • Synovial sarcoma is a very rare mesenchymal tumor that exhibits an epithelial profile.
  • To confirm the diagnosis of synovial sarcoma, we evaluated several immunohistochemical markers, or detected SYT-SSX fusion gene transcript.
  • We studied the clinicopathologic features in 92 synovial sarcoma patients and also assessed the immunohistochemical expression of dysadherin and E-cadherin to examine their possible association with histologic subtype and biologic behavior.
  • Synovial sarcoma patients with dysadherin expression survived for a significantly shorter time than those without dysadherin expression (P=0.0006).
  • Dysadherin expression is considered to be one of the determinants of histologic subtype in synovial sarcoma.
  • [MeSH-major] Biomarkers, Tumor / metabolism. Cadherins / metabolism. Membrane Glycoproteins / metabolism. Neoplasm Proteins / metabolism. Sarcoma, Synovial / metabolism. Soft Tissue Neoplasms / metabolism
  • [MeSH-minor] Adult. Disease Progression. Extremities. Female. Gene Expression. Humans. Immunoenzyme Techniques. Male. Mitotic Index. Oncogene Proteins, Fusion / genetics. Oncogene Proteins, Fusion / metabolism. Prognosis. RNA, Messenger / metabolism. Reverse Transcriptase Polymerase Chain Reaction. Survival Rate

  • Genetic Alliance. consumer health - Synovial sarcoma.
  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17197923.001).
  • [ISSN] 0147-5185
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Cadherins; 0 / FXYD5 protein, human; 0 / Membrane Glycoproteins; 0 / Neoplasm Proteins; 0 / Oncogene Proteins, Fusion; 0 / RNA, Messenger; 0 / SYT-SSX fusion protein
  •  go-up   go-down


86. Mentzel T: [Epithelioid sarcoma: morphologic variants and differential diagnosis]. Pathologe; 2010 Mar;31(2):135-41
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Epithelioid sarcoma: morphologic variants and differential diagnosis].
  • Epithelioid sarcoma represents a rare sarcoma with a poor long-term prognosis that arises predominantly on the distal extremities of young adult patients, often mimicking a benign, non-neoplastic condition.
  • Histologically, epithelioid sarcoma is characterized by a multinodular growth with central necrosis, and the neoplasms are composed of relatively uniform epithelioid tumour cells showing a coexpression of vimentin, epithelial membrane antigen and pancytokeratin, and in about half of the cases of CD34.
  • Interestingly, most cases of epithelioid sarcoma show a loss of INI1, whereas the inactivation of the tumour suppressor gene SMARCB1/INI1 is only rarely caused by mutation.
  • The proximal variant of epithelioid sarcoma is composed of confluent sheets of enlarged epithelioid and rhabdoid tumour cells and represents the morphological progression of this entity.
  • The fibroma-like variant of epithelioid sarcoma as well as the angiomatoid and myxoid variants of epithelioid sarcoma are rare morphological variants and need to be considered in the differential diagnosis of other benign and malignant neoplasms.
  • [MeSH-major] Sarcoma / pathology. Soft Tissue Neoplasms / pathology

  • Genetic Alliance. consumer health - Epithelioid Sarcoma.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Hum Pathol. 2009 Sep;40(9):1361-2; author reply 1362-4 [19683621.001]
  • [Cites] Am J Clin Pathol. 2009 Feb;131(2):222-7 [19141382.001]
  • [Cites] Cancer Res. 2005 May 15;65(10 ):4012-9 [15899790.001]
  • [Cites] Hum Pathol. 1999 Aug;30(8):934-42 [10452506.001]
  • [Cites] Cancer. 1970 Nov;26(5):1029-41 [5476785.001]
  • [Cites] Hum Pathol. 2009 Mar;40(3):349-55 [18973917.001]
  • [Cites] Am J Surg Pathol. 2009 Apr;33(4):542-50 [19033866.001]
  • [Cites] Am J Surg Pathol. 2007 Jan;31(1):99-105 [17197925.001]
  • [Cites] Virchows Arch A Pathol Anat Histopathol. 1991;418(3):271-8 [1900974.001]
  • [Cites] Mod Pathol. 2001 Jul;14(7):655-63 [11454997.001]
  • [Cites] Histopathology. 2001 Dec;39(6):641-3 [11903586.001]
  • [Cites] Am J Surg Pathol. 1985 Apr;9(4):241-63 [4014539.001]
  • [Cites] Adv Anat Pathol. 2006 May;13(3):114-21 [16778474.001]
  • [Cites] Cancer. 1992 Mar 15;69(6):1382-95 [1371711.001]
  • [Cites] Histopathology. 2010 Nov;57(5):753-9 [21083605.001]
  • [Cites] Am J Surg Pathol. 2007 Dec;31(12):1813-24 [18043035.001]
  • [Cites] Am J Surg Pathol. 2003 Jan;27(1):48-57 [12502927.001]
  • [Cites] Am J Surg Pathol. 2008 Aug;32(8):1168-74 [18580682.001]
  • [Cites] Am J Surg Pathol. 1997 Feb;21(2):130-46 [9042279.001]
  • [Cites] Int J Surg Pathol. 2009 Apr;17(2):147-52 [18480401.001]
  • (PMID = 19997734.001).
  • [ISSN] 1432-1963
  • [Journal-full-title] Der Pathologe
  • [ISO-abbreviation] Pathologe
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  • [Number-of-references] 21
  •  go-up   go-down


87. El Weshi A, Allam A, Ajarim D, Al Dayel F, Pant R, Bazarbashi S, Memon M: Extraskeletal Ewing's sarcoma family of tumours in adults: analysis of 57 patients from a single institution. Clin Oncol (R Coll Radiol); 2010 Jun;22(5):374-81
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Extraskeletal Ewing's sarcoma family of tumours in adults: analysis of 57 patients from a single institution.
  • AIMS: Extraskeletal Ewing's sarcoma (EES) is a rare form of soft tissue sarcoma.
  • The aim of the present study was to assess the outcome and the prognosis of adult patients presenting with EES treated with multi-modality therapy.
  • This series showed that the outcome of adult EES is not unlike that of skeletal Ewing's sarcoma in terms of response to multi-modality treatment and the prognostic factors influencing treatment outcome.
  • [MeSH-major] Sarcoma / pathology. Sarcoma / therapy. Sarcoma, Ewing / pathology. Sarcoma, Ewing / therapy
  • [MeSH-minor] Adolescent. Adult. Antineoplastic Combined Chemotherapy Protocols / administration & dosage. Combined Modality Therapy. Dactinomycin / administration & dosage. Disease-Free Survival. Doxorubicin / administration & dosage. Humans. Ifosfamide / administration & dosage. Kaplan-Meier Estimate. Middle Aged. Radiotherapy. Vincristine / administration & dosage. Young Adult

  • Genetic Alliance. consumer health - Ewing's Sarcoma.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • Hazardous Substances Data Bank. DOXORUBICIN .
  • Hazardous Substances Data Bank. IFOSFAMIDE .
  • Hazardous Substances Data Bank. DACTINOMYCIN .
  • Hazardous Substances Data Bank. VINCRISTINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
  • (PMID = 20466282.001).
  • [ISSN] 1433-2981
  • [Journal-full-title] Clinical oncology (Royal College of Radiologists (Great Britain))
  • [ISO-abbreviation] Clin Oncol (R Coll Radiol)
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 1CC1JFE158 / Dactinomycin; 5J49Q6B70F / Vincristine; 80168379AG / Doxorubicin; UM20QQM95Y / Ifosfamide
  •  go-up   go-down


88. Liebl LS, Elson F, Quaas A, Gawad KA, Izbicki JR: Value of repeat resection for survival in pulmonary metastases from soft tissue sarcoma. Anticancer Res; 2007 Jul-Aug;27(4C):2897-902
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Value of repeat resection for survival in pulmonary metastases from soft tissue sarcoma.
  • BACKGROUND: Pulmonary metastasectomy in soft tissue sarcoma (STS) can lead to long-term survival.
  • PATIENTS AND METHODS: Seventy-eight pulmonary metastasectomies were performed on 42 STS patients from 1990 to 2005.
  • Thus, lacking randomised controlled data of the natural course of patients with unresected lung metastases to compare these results, metastasectomy in STS patients is also recommended in recurrent disease.
  • [MeSH-major] Lung Neoplasms / secondary. Lung Neoplasms / surgery. Sarcoma / secondary. Sarcoma / surgery
  • [MeSH-minor] Adolescent. Adult. Aged. Humans. Middle Aged. Neoplasm Staging. Reoperation. Survival Rate. Treatment Outcome


89. Henriques de Figueiredo B, Kantor G, Bui Nguyen Binh M, Duparc A, Guerder C, Stoeckle E, Coindre JM, Bui BN: [Epithelioid sarcoma: a retrospective study of conservative treatment with initial surgery and radiotherapy]. Cancer Radiother; 2007 Sep;11(5):227-33
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Epithelioid sarcoma: a retrospective study of conservative treatment with initial surgery and radiotherapy].
  • INTRODUCTION: Epithelioid sarcoma is a rare type of soft tissue sarcomas with a high risk of recurrence both local and distant.
  • [MeSH-major] Sarcoma / therapy
  • [MeSH-minor] Adolescent. Adult. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Arm. Female. Follow-Up Studies. Hand. Humans. Knee. Lymphatic Metastasis. Male. Middle Aged. Neoplasm Recurrence, Local. Pectoralis Muscles. Perineum. Postoperative Care. Radiotherapy Dosage. Radiotherapy, Adjuvant. Retrospective Studies. Time Factors. Treatment Outcome

  • Genetic Alliance. consumer health - Epithelioid Sarcoma.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17652004.001).
  • [ISSN] 1278-3218
  • [Journal-full-title] Cancer radiothérapie : journal de la Société française de radiothérapie oncologique
  • [ISO-abbreviation] Cancer Radiother
  • [Language] fre
  • [Publication-type] Comparative Study; English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


90. Ryan CW, Montag AG, Hosenpud JR, Samuels B, Hayden JB, Hung AY, Mansoor A, Peabody TD, Mundt AJ, Undevia S: Histologic response of dose-intense chemotherapy with preoperative hypofractionated radiotherapy for patients with high-risk soft tissue sarcomas. Cancer; 2008 Jun;112(11):2432-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Histologic response of dose-intense chemotherapy with preoperative hypofractionated radiotherapy for patients with high-risk soft tissue sarcomas.
  • BACKGROUND: The authors studied a dose-intense regimen of epirubicin and ifosfamide with hypofractionated preoperative radiotherapy for high-risk soft tissue sarcomas.
  • METHODS: Twenty-five patients with intermediate-grade or high-grade, localized soft tissue sarcomas of the extremity or body wall measuring >5 cm were treated with epirubicin at a dose of 30 mg/m(2)/day on Days 1 to 4 and ifosfamide at a dose of 2.5 g/m(2)/day on Days 1 to 4 every 21 days for 3 preoperative and 3 postoperative cycles.
  • [MeSH-major] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Sarcoma / therapy. Soft Tissue Neoplasms / therapy
  • [MeSH-minor] Adult. Aged. Combined Modality Therapy. Dose Fractionation. Epirubicin / administration & dosage. Female. Humans. Ifosfamide / administration & dosage. Male. Middle Aged. Neoplasm Staging. Preoperative Care. Risk Factors. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. IFOSFAMIDE .
  • Hazardous Substances Data Bank. EPIRUBICIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Cancer. 2008 Jun;112(11):2338-40 [18338757.001]
  • (PMID = 18348295.001).
  • [ISSN] 1097-0142
  • [Journal-full-title] Cancer
  • [ISO-abbreviation] Cancer
  • [Language] eng
  • [Publication-type] Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 3Z8479ZZ5X / Epirubicin; UM20QQM95Y / Ifosfamide
  •  go-up   go-down


91. Hersekli MA, Ozkoc G, Bircan S, Akpinar S, Ozalay M, Tuncer I, Tandogan RN: Primary clear cell sarcoma of rib. Skeletal Radiol; 2005 Mar;34(3):167-70
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary clear cell sarcoma of rib.
  • Clear cell sarcoma (malignant melanoma of soft tissues) is a very rare soft tissue neoplasm.
  • Although metastasis of malignant melanoma to bone is not uncommon, primary clear cell sarcoma of bone is an extremely rare neoplasm.
  • We present a case of primary clear cell sarcoma of bone in a 28-year-old woman arising in the left ninth rib.
  • [MeSH-major] Bone Neoplasms / diagnostic imaging. Ribs. Sarcoma, Clear Cell / diagnostic imaging
  • [MeSH-minor] Adult. Combined Modality Therapy. Diagnosis, Differential. Female. Humans. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer. 1996 Jun 15;77(12):2471-5 [8640695.001]
  • [Cites] Skeletal Radiol. 2003 Oct;32(10 ):598-602 [14513295.001]
  • [Cites] Genes Chromosomes Cancer. 1993 Apr;6(4):249-52 [7685631.001]
  • [Cites] Br J Cancer. 2001 Feb;84(4):535-8 [11207050.001]
  • [Cites] Skeletal Radiol. 2000 Apr;29(4):187-95 [10855466.001]
  • [Cites] AJR Am J Roentgenol. 1990 Nov;155(5):1025-30 [2120930.001]
  • [Cites] Skeletal Radiol. 2003 Oct;32(10 ):594-7 [12904909.001]
  • [Cites] Cancer. 1965 Sep;18:1163-74 [14332545.001]
  • [Cites] Cancer Genet Cytogenet. 2001 Oct 1;130(1):1-7 [11672766.001]
  • [Cites] J Am Podiatr Med Assoc. 1998 Sep;88(9):457-61 [9770939.001]
  • [Cites] Eur J Cancer. 1991;27(3):254-6 [1827307.001]
  • [Cites] Skeletal Radiol. 1999 Apr;28(4):240-3 [10384998.001]
  • [Cites] Am J Surg Pathol. 1992 Dec;16(12):1197-204 [1463095.001]
  • (PMID = 15592669.001).
  • [ISSN] 0364-2348
  • [Journal-full-title] Skeletal radiology
  • [ISO-abbreviation] Skeletal Radiol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


92. Morii T, Mochizuki K, Takushima A, Okazaki M, Satomi K: Soft tissue reconstruction using vascularized tissue transplantation following resection of musculoskeletal sarcoma: evaluation of oncologic and functional outcomes in 55 cases. Ann Plast Surg; 2009 Mar;62(3):252-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Soft tissue reconstruction using vascularized tissue transplantation following resection of musculoskeletal sarcoma: evaluation of oncologic and functional outcomes in 55 cases.
  • Oncologic resection of musculoskeletal sarcoma sometimes requires reconstruction with vascularized soft tissue transplantation.
  • [MeSH-major] Bone Neoplasms / surgery. Reconstructive Surgical Procedures. Sarcoma / surgery. Soft Tissue Neoplasms / surgery. Surgical Flaps / blood supply. Wounds and Injuries / surgery
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Child. Female. Humans. Male. Middle Aged. Recovery of Function. Treatment Outcome. Young Adult


93. Sharma H, Jane MJ, Reid R: Pigmented villonodular synovitis of the foot and ankle: Forty years of experience from the Scottish bone tumor registry. J Foot Ankle Surg; 2006 Sep-Oct;45(5):329-36
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The anatomical sites were phalanges (n = 2), tarso-metatarsal area (n = 3), and hindfoot (n = 9) (6 extraarticular soft tissue swellings around the ankle, 2 ankle, 1 subtalar joint).
  • Peri-articular tissue invasion and cortical infiltration were found in one third on plain films.
  • Magnetic resonance imaging findings were suggestive of synovial sarcoma in 2 cases because of extensive low-signal soft tissue hypertrophy and bone erosion.
  • [MeSH-minor] Adolescent. Adult. Child. Female. Humans. Magnetic Resonance Imaging. Male. Middle Aged. Recurrence

  • Genetic Alliance. consumer health - Pigmented villonodular synovitis.
  • Genetic Alliance. consumer health - Synovitis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16949531.001).
  • [ISSN] 1067-2516
  • [Journal-full-title] The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons
  • [ISO-abbreviation] J Foot Ankle Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


94. Li L, Cen S, Huang F: [Clinical research on 11 cases of epithelioid sarcoma]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Dec;21(12):1315-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Clinical research on 11 cases of epithelioid sarcoma].
  • OBJECTIVE: To investigate the clinical features, diagnosis, and treatment of patients with localized epithelioid sarcoma (ES).
  • [MeSH-major] Sarcoma / diagnosis. Sarcoma / surgery. Surgical Flaps. Upper Extremity / surgery
  • [MeSH-minor] Adolescent. Adult. Amputation. Bone Transplantation. Female. Hand / pathology. Hand / surgery. Humans. Lower Extremity / pathology. Lower Extremity / surgery. Male. Neoplasm Metastasis. Neoplasm Recurrence, Local. Soft Tissue Injuries / surgery. Treatment Outcome. Young Adult

  • Genetic Alliance. consumer health - Epithelioid Sarcoma.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18277674.001).
  • [ISSN] 1002-1892
  • [Journal-full-title] Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery
  • [ISO-abbreviation] Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


95. Schöffski P, Breidenbach I, Krauter J, Bolte O, Stadler M, Ganser A, Wilhelm-Ogunbiyi K, Lentzen H: Weekly 24 h infusion of aviscumine (rViscumin): a phase I study in patients with solid tumours. Eur J Cancer; 2005 Jul;41(10):1431-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Colorectal cancer, soft tissue sarcoma and pancreatic cancer were the most common tumour types.
  • [MeSH-minor] Adult. Aged. Disease Progression. Female. Humans. Infusions, Intravenous. Male. Maximum Tolerated Dose. Middle Aged. Recombinant Proteins. Ribosome Inactivating Proteins, Type 2

  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15913988.001).
  • [ISSN] 0959-8049
  • [Journal-full-title] European journal of cancer (Oxford, England : 1990)
  • [ISO-abbreviation] Eur. J. Cancer
  • [Language] eng
  • [Publication-type] Clinical Trial; Clinical Trial, Phase I; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Phytogenic; 0 / Plant Preparations; 0 / Plant Proteins; 0 / Recombinant Proteins; 0 / Ribosome Inactivating Proteins, Type 2; 0 / Toxins, Biological; 0 / ribosome inactivating protein, Viscum
  •  go-up   go-down


96. Valdivia Gómez GG, Soto Guerrero MT, Cedillo de la Cruz MI: Extra-skeletal Ewing's sarcoma resembling acute abdomen. Case report. Cir Cir; 2010 Mar-Apr;78(2):159-62
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Extra-skeletal Ewing's sarcoma resembling acute abdomen. Case report.
  • BACKGROUND: Extraosseous Ewing's sarcoma is a rare tumor of neuroectodermal origin.
  • It presents mainly in the soft tissue of the extremities and thorax.
  • Histologically, it is similar to Ewing's sarcoma of the bone.
  • CONCLUSIONS: In a review of the literature, no previous reports of extraosseous Ewing's sarcoma were found presenting as acute abdomen.
  • [MeSH-major] Abdomen, Acute / diagnosis. Retroperitoneal Neoplasms / diagnosis. Sarcoma, Ewing / diagnosis
  • [MeSH-minor] Adult. Diagnosis, Differential. Humans. Male

  • Genetic Alliance. consumer health - Ewing's Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20478118.001).
  • [ISSN] 0009-7411
  • [Journal-full-title] Cirugía y cirujanos
  • [ISO-abbreviation] Cir Cir
  • [Language] eng; spa
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Mexico
  •  go-up   go-down


97. Yonemoto T, Tatezaki S, Ishii T, Iwata S, Takeuchi Y, Araki A: Histological vascular invasion by tumors is a risk factor for distant metastasis in malignant fibrous histiocytoma. Anticancer Res; 2005 Mar-Apr;25(2B):1337-42
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: The appearance of distant metastasis is a fatal sign in patients with soft tissue sarcoma.
  • [MeSH-minor] Adolescent. Adult. Age Factors. Aged. Female. Humans. Male. Middle Aged. Multivariate Analysis. Neoplasm Invasiveness / pathology. Neoplasm Metastasis. Retrospective Studies. Risk Factors

  • Genetic Alliance. consumer health - Malignant fibrous histiocytoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15865088.001).
  • [ISSN] 0250-7005
  • [Journal-full-title] Anticancer research
  • [ISO-abbreviation] Anticancer Res.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Greece
  •  go-up   go-down


98. Sun L, Wu LY, Li XG, Bai P, Zhang HT: [Clinical characterization of vulvar epithelioid sarcoma]. Zhonghua Zhong Liu Za Zhi; 2010 Dec;32(12):935-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Clinical characterization of vulvar epithelioid sarcoma].
  • OBJECTIVE: Vulvar epithelioid sarcoma is a rare, undifferentiated soft-tissue sarcoma, with a high rate of local relapse, regional nodal spread and distant metastases.
  • METHODS: We studied the clinicopathologic features of 20 cases of vulvar epithelioid sarcoma, of which 4 cases were admitted to our hospital from 1999 to 2009.
  • Radical local excision with adequate margin (at least 2 cm) and bilateral inguinofemoral lymphadenectomy is effective for the treatment of vulvar epithelioid sarcoma.
  • [MeSH-major] Sarcoma / pathology. Sarcoma / surgery. Soft Tissue Neoplasms / pathology. Soft Tissue Neoplasms / surgery. Vulvar Neoplasms / pathology. Vulvar Neoplasms / surgery
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Chemotherapy, Adjuvant. Female. Follow-Up Studies. Humans. Keratins / metabolism. Lymph Node Excision. Lymphatic Metastasis. Middle Aged. Mucin-1 / metabolism. Neoplasm Staging. Radiotherapy, Adjuvant. Retrospective Studies. Survival Rate. Vimentin / metabolism. Vulva / surgery. Young Adult


99. Papagelopoulos PJ, Mavrogenis AF, Mastorakos DP, Vlastou C, Vrouvas J, Soucacos PN: Free vascularised tissue transfer and brachytherapy for soft-tissue sarcomas of the extremities. Injury; 2008 Sep;39 Suppl 3:S83-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Free vascularised tissue transfer and brachytherapy for soft-tissue sarcomas of the extremities.
  • SUMMARY: We reviewed the medical files of nine patients with localised soft-tissue sarcomas of the extremities treated with surgical resection, free vascularised tissue transfer, and computerised after-loading iridium-192 high dose rate brachytherapy over a period of 8 years.
  • Microsurgical reconstruction of the soft-tissue defect used a free vascularised musculocutaneous flap that included the gracilis flap in five patients, the latissimus dorsi flap in four patients, and the radiovolar flap in one patient.
  • Tumour resection for soft-tissue sarcomas combined with microsurgical reconstruction of the soft-tissue defect, preoperative external beam radiation and high dose rate brachytherapy results in a high degree of local control with acceptable complications.
  • [MeSH-major] Brachytherapy / methods. Extremities / surgery. Sarcoma / surgery. Soft Tissue Neoplasms / surgery. Surgical Flaps / blood supply
  • [MeSH-minor] Adult. Aged. Combined Modality Therapy. Dose Fractionation. Female. Follow-Up Studies. Humans. Limb Salvage / methods. Male. Microsurgery / methods. Middle Aged. Muscle, Skeletal / transplantation. Reconstructive Surgical Procedures / methods. Skin Transplantation / methods. Young Adult

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18687428.001).
  • [ISSN] 1879-0267
  • [Journal-full-title] Injury
  • [ISO-abbreviation] Injury
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


100. Ohmiya N, Taguchi A, Mabuchi N, Itoh A, Hirooka Y, Niwa Y, Goto H: MDM2 promoter polymorphism is associated with both an increased susceptibility to gastric carcinoma and poor prognosis. J Clin Oncol; 2006 Sep 20;24(27):4434-40
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PURPOSE: Recently, a single-nucleotide polymorphism in the MDM2 promoter (SNP309) has been found to lower the age of onset of tumors and increase the occurrence of multiple primary tumors in Li-Fraumeni syndrome, and accelerate the development of sporadic adult soft tissue sarcoma.
  • Tumor tissue was immunostained with p53 and examined for mutations in exons 5 to 8 of p53 using polymerase chain reaction-based single strand conformational polymorphism analysis and direct sequencing.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Case-Control Studies. Female. Genes, p53. Genetic Markers / genetics. Genetic Predisposition to Disease. Genotype. Humans. Male. Middle Aged. Mutation. Odds Ratio. Polymerase Chain Reaction. Polymorphism, Single Nucleotide. Polymorphism, Single-Stranded Conformational. Predictive Value of Tests. Prognosis. Promoter Regions, Genetic. Risk Assessment. Risk Factors. Survival Analysis

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16983111.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Genetic Markers; EC 6.3.2.19 / MDM2 protein, human; EC 6.3.2.19 / Proto-Oncogene Proteins c-mdm2
  •  go-up   go-down






Advertisement